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Abstract
The purpose of this study was to evaluate the effectiveness of heart rate variability
biofeedback (HRV BFB), a form of psychophysiological skills intervention, to improve athletes’
psychological response following an injury. Further, to examine the effects of HRV BFB on
self-efficacy, perceived stress and anxiety, pain management, and the psychological responses of
injured athletes. HRV BFB effects on athletes’ physiological indices including HRV, HR, and
respiration rate were also assessed. Participants were 32 athletes who had sustained a moderate
to severe musculoskeletal sports injury, ranging in age from 18 to 36 years (Mage = 20.82, SD =
3.41). All participants were out of training and competition and engaged in a rehabilitation
program. This investigation was experimental in nature with a randomized, single-blinded study
design. Participants were randomized into one of three groups: HRV BFB Experimental group,
HRV BFB Placebo group, or Control group. Assessments of psychological outcomes and
physiological indices were assessed at Baseline, Week 1, Week 2, and Week 3. Compared with
the participants in either the Placebo or Control groups, participants who received the HRV BFB
intervention reported significantly greater reductions in psychological responses of devastation,
reorganization, and isolation, (b) significantly greater declines in magnification regarding pain,
(c) significantly greater improvements in LF HRV during rest, and (d) significantly greater
declines in resting respiration rate. The findings suggest that HRV BFB may hold potential to
improve athletes’ psychological response after sustaining an injury and that it shows promise as a
useful psychological skills intervention for injury rehabilitation.
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Chapter 1: Review of Literature
Participation in sport of any nature brings with it the possibility of athletic injury.
Demonstrating this, Statistics Canada conducted a Community Health Survey, in which it was
found that from 2009-2010, approximately 35% of injuries were a result of participation in sport
and exercise (Statistics Canada, 2011). Further, it was shown that amongst the population aged
12 and over, sport and exercise was the leading cause of serious injury amounting to an
overwhelming 1,470,000 incidents (Statistics Canada, 2011). Hence, it appears that in sport, the
occurrence of an injury is almost inevitable and depending on the type and severity of the injury,
a lengthy rehabilitation period may ensue. Rehabilitation, often comprised of physiotherapy,
presents the athlete with many challenges, both physical and psychological. Beyond the obvious
physical limitations the injury evokes, the unsightly visual appearance, and physical therapy that
follows, an injury can take a toll on an athletes' emotions and contribute to psychological distress
in several ways.
1.1 Psychological Response to Injury Theories
While the physical aspects of an injury have and continue to be the focal point of injury
research, a number of theoretical models have been adapted and deemed useful as frameworks
for examining the psychological response to athletic injury (Walker, Thatcher, & Lavallee,
2007). For instance, Kubler-Ross (1969) constructed the Stage Approach to Grief Management
through which it was proposed that grieving individuals experience and must deal with five
emotional stages in a sequential order. These stages include: denial, anger, bargaining,
depression, and acceptance (Kubler-Ross, 1969). Research on psychosocial responses to sport
injury has provided partial support for this construct; however, certain stages (depression and
anger) seem to be more prevalent amongst injured athletes than others (Walker et al., 2007). In
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order to address the limitations associated with the previous model, Wiese-Bjornstal, Smith,
Shaffer, and Morrey (1998) constructed the integrated model of psychological response to the
sport injury and rehabilitation process. This model was centered on athlete’s cognitive
appraisals, which are thought to influence ensuing recovery outcomes (Walker et al., 2007).
Cognitive appraisals are considered to be processes in which an athlete perceives an
event/situation as stressful and subsequently assesses the extent to which they are able to deal
with the stress encountered. The model proposed that in the occurrence of an injury, an athlete’s
cognitive appraisal is influenced by both personal (e.g., personality, history of injury) and
situational factors (e.g., level of competition, time of season). Further, how the athlete appraises
the injury will subsequently determine the athlete’s emotional and behavioural responses to the
rehabilitation process (Wiese-Bjornstal et al., 1998). To date, a large portion of the research
surrounding the psychological response to athletic injury has been centered on the emotional
responses evoked by injury. However, Evans, Wadey, Hanton, and Mitchell (2012) examined
the various stressors that triggered adverse emotions experienced by injured athletes and found
that at onset of injury, a number of stressors are perceived as taxing including incapacitation,
missed opportunities, loss of independence, and social comparison. During the injury
rehabilitation phase, stressors including lack of rehabilitation progress, loss of fitness, and fear of
not being able to perform at pre-injury levels were cited (Evans et al., 2012). This research was
successful in highlighting the wide range of factors that can influence an athlete’s thoughts,
emotions, and behavior during recovery.
1.2 Psychological Impact of Injury
In many cases, recovery can be a long and difficult process, where improvement gains are
sluggish. The result for many athletes, who do not recognize the extent and requirements of
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rehabilitation, is a period of emotional distress and test of their mental toughness. Injured
athletes face many challenges throughout rehabilitation. Cognitively, athletes need to understand
the nature of the injury; emotionally, they must deal with numerous adverse emotions; and
behaviorally, they must actively cope with their condition (Fisher, Scriber, Matheny, Alderman,
& Bitting, 1993).
It has been shown that injury rehabilitation, particularly the initial phase of sustaining the
injury, is associated with the greatest mood disturbance and adverse emotionality (Tracey, 2003).
The emphasis of an investigation by Tracey (2003) was examining the emotional response to the
injury and rehabilitation process in college level athletes. The findings demonstrated the
dynamic and multidimensional nature of the psychological response to athletic injury and
subsequent recovery. Tracey (2003) described athletes as experiencing a “roller coaster” of
emotions as they attempted to cope with their injury and the rehabilitation period they were
confronted with. Research has identified common feelings expressed by injured athletes, which
may consist of anger, depression, frustration, decreased self-esteem, and feelings of helplessness.
Athletes have also shown signs of being afraid, confused, worried, and anxious (Fisher et al,
1993; Green & Weinberg, 2001; Tracey, 2003). Furthermore, Sonestrom and Morgan (1989)
found that the occurrence of an injury could negatively influence an athlete’s self-esteem,
physical self-efficacy, and perceived competence in their physical ability. Providing additional
evidence for the emotional toll that an injury and subsequent recovery can have on athletes, it
was demonstrated that clinician-based depressive symptoms in athletes with injuries surpassed
those of healthy controls at 1 week post-injury, with symptoms persisting at 1 month following
the injury onset (Appaneal, Levine, Perna, & Roh, 2009). In terms of depressive symptoms and
mood disturbances experienced by injured athletes, research has demonstrated a negative
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relationship between athletic identity and adverse emotional impact after sustaining an injury. It
appears that highly competitive athletes are particularly vulnerable to experiencing psychological
distress and mood disturbances associated with rehabilitation due to their sense of athletic
identity being threatened (Brewer, 1993).
In addition to the numerous unfavorable emotions and psychological impact that may
occur following an injury, there is the obvious relationship between injury and the consequence
of pain. Research has indicated that pain and discomfort associated with injury can discourage
athletes and prevent them from achieving their rehabilitation goals (Fisher et al., 1993). Overall,
it is clear that the experience of an athletic injury can be an extremely taxing period, consisting
of both physical and psychological demands in order to achieve a successful recovery. Further,
it is apparent that the injury and subsequent recovery period has the potential to have a negative
impact on the athlete’s emotions and psychological state.
1.3 Positive Psychological Traits Associated with Injury Recovery
Therefore, it is not surprising that researchers have begun to explore psychological
factors associated with positive rehabilitation outcomes. Various psychological traits and/or
factors have been shown to be valuable in the recovery from an athletic injury. Identification of
these psychological traits regarded as beneficial to the recovery process is important in order to
prevent athletes from demonstrating negative psychological responses to injury and
rehabilitation. For instance, Fisher et al. (1993) expressed the importance of encouraging
athletes to increase their involvement in rehabilitation, have positive self-thoughts regarding
recovery, and to remain motivated and confident. Similarly, Manuel et al. (2002) found that
positive stress and increased social support were associated with reduced depressive symptoms
in injured athletes. These findings speak to the importance of providing injured athletes with
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support, and allowing them to feel proactive, informed, and involved in their rehab experience so
that they can retain a certain degree of positive stress and uphold characteristics indicative of
their ‘athletic identity’. In a review of the literature, Brewer (1998) examined psychological
traits associated with rehabilitation adherence and positive recovery outcomes. Several factors
have demonstrated a positive relationship with adherence including self-motivation, pain
tolerance, task involvement, and mental toughness. Further, traits such as attributing recovery to
personally controllable factors, perceived ability to cope with the injury, emotional adjustment,
instrumental coping and self-efficacy for rehabilitation have been shown to enhance adherence to
rehabilitation (Brewer, 1998).
A study investigating the relationships between self-efficacy, imagery use, and adherence
during injury rehabilitation concluded that there was a moderate to strong relationship between
self-efficacy and adherence (Wesch et al., 2012). Self-efficacy refers to an individual’s belief in
his/her ability to engage in a situation-specific behavior and obtain a desired outcome (Bandura,
1986). Wesch et al. (2012) advocated for the development of interventions to improve selfefficacy in the injury rehabilitation environment, because of its potential to promote adherence
and improve recovery outcomes. Likewise, research conducted by Nicholls, Polman, and Levy
(2010) indicated that there was a significant, inverse relationship between coping self-efficacy
and both somatic and cognitive anxiety. Coping self-efficacy can be defined as a person’s belief
in his/her ability to implement strategies deemed beneficial in dealing with threats and managing
reactions to stress (Bandura, 1997). The ability to cope with the numerous stressors and elevated
levels of negative affect experienced during rehabilitation clearly would be of benefit to the
injured athlete. This was further exemplified through research indicating that coping strategies
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could help injured athletes manage mood disturbances and adverse psychological states
associated with injury (Green & Weinberg, 2001; Udry, 1997).
1.4 Psychological Skills Training
Over the years, researchers have demonstrated the integral role of psychosocial factors in
the occurrence of injuries and the subsequent recovery process (Brewer, Jeffers, Petitpas, & Van
Raalte, 1994). Further, researchers have strived to create awareness of the psychological impact
an injury may have on injured athletes. To manage the extent of negative affect following an
injury, several researchers have investigated the influence of psychological factors and how these
may affect an athlete's emotional state throughout their recovery. Additionally, researchers have
begun exploring the implementation of psychological strategies to assist individuals in their
rehabilitation process; these include goal setting (Evans & Hardy, 2002), positive self-talk, stress
inoculation training (Ross & Berger, 1996), cognitive restructuring, modeling (Maddison,
Prapavessis, & Clatworthy, 2006), and imagery (Cupal & Brewer, 2001; Law, Driediger, Hall, &
Forwell, 2006; Wesch et al., 2012).
For instance, Evans and Hardy (2002) found that implementing a goal-setting program
with injured athletes led to significant improvements in rehabilitation adherence and perceived
self-efficacy. Further, when examining the psychological responses of athletes post-injury, it
was found that athletes showed significant reductions in dispirited, characterized by feelings of
apathy and a loss of motivation, along with significant improvements in reorganization,
characterized by feeling of confidence and sense of psychological recovery across time (Evans &
Hardy, 2002). Similarly, Ross and Berger (1996) implemented a stress inoculation training
program with athletes undergoing arthroscopic surgery for meniscus injury. Results indicated
that those in the treatment group experienced significantly less postsurgical pain and anxiety
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during the rehabilitation process, compared to their control group counterparts. The potential
benefits of psychological skills training interventions in the athletic injury rehabilitation setting
was further demonstrated by Maddison et al. (2006) who provided athletes undergoing ACL
reconstruction with a modeling intervention. Findings demonstrated that those who received the
modeling intervention reported significantly lower perceptions of expected pain preoperatively,
greater self-efficacy for rehabilitation, and improved functional outcome scores compared to the
control participants. Additionally, Cupal and Brewer (2001) found that athletes undergoing ACL
reconstruction who received a guided imagery and relaxation intervention experienced
significantly less anxiety and pain than those in a placebo and control group. Therefore, it
appears that the implementation of psychological skills training interventions in a rehabilitation
setting have the potential to assist athletes throughout their recovery and facilitate improved
psychological and functional outcomes.
Despite this, it appears that rehabilitation for injured athletes is still centered
predominantly on the physical aspects of the injury, with a lack of attention being given towards
intervention that facilitates the athletes psychologically throughout their rehabilitation and
recovery. This is surprising given the evidence, which has indicated that unnecessary injuries
occur and that recovery can be compromised because of a failure to address psychological
factors during the rehabilitation process (Cupal, 1998). Use of psychological skills training
interventions such as imagery, positive self-talk, relaxation, and goal setting have been shown to
be positively correlated with healing times, successful rehabilitation, recovery rates, and
satisfaction with rehabilitation (Cupal, 1998). Furthermore, in a review of the psychological
intervention in athletic injury rehabilitation literature, all rehabilitation interventions have been
associated with at least one positive outcome, whether it be greater recovery of physical strength,
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increased physical functioning, reduced pain, stress, and anxiety, or improved mood (Cupal,
1998). From these findings, it is clear that continued research into the development and
implementation of psychological interventions during rehabilitation from sport injury should be
encouraged.
1.5 The Use of Heart Rate Variability Biofeedback and Related Physiology
Another form of psychological skills training that has been shown to demonstrate
considerable potential in a number of research environments, within the field of
psychophysiology, is known as biofeedback (BFB). Biofeedback modalities are applied to
obtain self-regulation of bodily functions. The goal of BFB is to increase voluntary control over
the physiological processes that are otherwise outside one’s awareness, by using information
about them in the form of an external signal or cue (Paul, Garg, & Sandhu, 2012). Several
methods of BFB have been used in both research and applied settings, including peripheral
modalities (e.g., electromyography, electrodermal response, heart rate, skin temperature, blood
volume pulse) and central modalities (e.g., neurofeedback or electroencephalography) (PopJordanova & Demerdzieva, 2010). However, one modality of biofeedback that is of particular
interest is heart rate variability biofeedback (HRV BFB). Heart rate variability (HRV) refers to
the beat-to-beat changes in the duration of RR intervals (RRIs) in the electrocardiogram (ECG).
Further, HRV can be expressed as variability in the duration of interbeat intervals (IBIs) between
consecutive heart beats (Lagos et al., 2008). According to Appelhans and Luecken (2006),
“HRV is a measure of the continuous interplay between sympathetic and parasympathetic
influences on heart rate (HR) that yields information about autonomic responsiveness and,
thereby represents the capacity for regulated emotional responding” (p. 230). Additionally, HRV
has been suggested to be a reliable assessment of autonomic function, an index of cardiovascular
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adaptability, and lastly, as being indicative of autonomic or sympathovagal balance (Paul &
Garg, 2012; Karavidas et al., 2007; Riganello, Garbarino, & Sannita, 2012).
The heart is dual innervated by both, the sympathetic and parasympathetic branches of
the autonomic nervous system (ANS). These two branches are functionally opposing of one
another, thereby exerting a regulatory effect on HR through influencing the activity of the
sinoatrial (SA) node, the heart’s primary pacemaker (Appelhans & Luecken, 2006). HR is
increased through activation of the sympathetic branch of the ANS, which exerts an excitatory
function over the SA node. In contrast, activation of the parasympathetic branch of the ANS
produces a decrease in HR through its influence on the activity of the SA node (Appelhans &
Luecken, 2006; Lagos et al., 2008). It has been suggested that through influencing cardiac
activity, the two branches of the ANS regulate the duration of IBIs, with a slower HR having
longer IBIs and a faster HR consisting of shorter IBIs (Appelhans & Luecken, 2006). However,
a healthy heart and its rhythm are influenced by a number of factors, both internal and external,
therefore, the heart does not beat with absolute regularity. As influenced by the ANS, changes in
HR can be a result of physiological indicators in attempts to maintain homeostasis, such as
oxygen and carbon dioxide levels in the blood, blood pressure, body temperature, and respiration
rate. Further, HR is influenced by external factors such as behavioural and physical changes,
consisting of exercise or fluctuating emotions (Lagos et al., 2008). The ANS functions to
maintain homeostasis in the human body, and as a result, responds to respiratory changes,
thermoregulatory changes, and input from a number of visceral receptors through the interplay of
its sympathetic (SNS) and parasympathetic (PNS) branches (Riganello, Garbarino, & Sannita,
2012). The SNS and PNS have been shown to interact antagonistically and therefore, activity of
a particular branch becomes dominant under different situational demands and each exerts an
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opposing effect on physiological arousal (Appelhans & Luecken, 2006).
According to Appelhans and Luecken (2006), a flexible and healthy functioning ANS
allows for physiological and emotional states to be altered in synchrony with changing
situational demands, whereas, a less responsive ANS does not allow timely modulation of
physiological and psychological states in response to a changing environment. Similarly, with
HRV deemed to be an indicator of autonomic and cardiorespiratory functioning, Wheat and
Larkin (2010) proposed that higher HRV represents the autonomic nervous system’s ability to
alter physiological arousal in accordance with situational demands, while low HRV has been
related to decreased physiological responsiveness to changing environmental circumstances, with
greater susceptibility to stress and disease. Considered to be an indicator of impaired autonomic
functioning, low HRV has been shown to be associated with a number of chronic illnesses and
psychological health conditions such as coronary heart disease, heart failure, asthma, posttraumatic stress disorder (PTSD), anxiety, depression, and fibromyalgia (Wheat & Larkin, 2010).
In contrast, higher HRV has been shown to reflect improved adaptability of physiological
arousal, in addition to a greater capacity for regulated emotional responding (Appelhans &
Luecken, 2006).
Hence, HRV BFB training is designed to produce increases in HRV and to improve
autonomic reactivity (Hassett et al., 2007). Through research, it has been demonstrated that
changes in HR due to sympathetic activation take place rather slowly, whereas parasympathetic
regulation on cardiac function has a very short response time, with changes in HR due to PNS
activation occurring much faster (Appelhans & Luecken, 2006). Therefore, the oscillations in
HR produced by the parasympathetic and sympathetic branches occur at different rates or
frequencies (Appelhans & Luecken, 2006). In other words, the amplitudes of HRV in these
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different frequency ranges are reflective of particular sources of autonomic control (Lehrer,
Vaschillo, & Vaschillo, 2000). According to Karavidas et al. (2007), HRV in the frequency
range of 0.005-0.05 Hz, considered to be a very low frequency band, is under control of the
sympathetic nervous system and may be indicative of thermal control, and baroreflex control of
blood pressure (BP) through changes in total peripheral resistance. HRV in the low frequency
range, 0.05-0.15 Hz, is controlled by both sympathetic and parasympathetic branches of the ANS
and may also reflect thermal control, and baroreflex control of BP through changes in heart rate.
Lastly, HRV in the frequency range of 0.15-0.4 Hz, referred to as the high frequency band, is
thought to be under control of the PNS and is related to respiratory activity (Karavidas et al.,
2007).
It is clear that oscillations in HR can be a result of several internal mechanisms; however,
a phenomenon known as respiratory sinus arrhythmia (RSA) is the variation in HR that
accompanies respiration (Lehrer et al., 2000). During inhalation, HR has been shown to
increase, whereas during exhalation, it has been shown to decrease (Vaschillo, Vaschillo, &
Lehrer, 2006). Research has shown that in order for individuals to maximize their respiratory
sinus arrhythmia, respiratory rates have to be reduced through paced breathing to approximately
0.1 Hz, or roughly 6 breaths per minute (Lehrer et al., 2003; Vaschillo et al., 2006). It has been
proposed that through paced breathing at this frequency, resonance occurs within the
cardiovascular system, thereby eliciting high-amplitude HR oscillations (Lehrer et al., 2000;
Lehrer et al., 2003; Vaschillo et al., 2006). Maximal amplitudes of HRV have been found to be a
result of resonance occurring between cardiac rhythms associated with respiration, and those
related to baroreflex activity (Vaschillo et al., 2006). The arterial baroreceptors function to
control changes in BP by evoking reflexes that result in either an increase or decrease in HR to
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compensate for the shift in BP. As stated by Vaschillo et al. (2006), “both HR and BP vary in
the closed-loop, so that a change in either function causes a change in the other. However, HR
reactions to BP shifts, as well as BP reactions to HR shifts are not instantaneous” (p. 130).
Through breathing at the resonant frequency (~0.1 Hz), it has been found that HR oscillates 180°
out of phase with BP, while HR and respiration oscillate in phase with each other (Lehrer et al.,
2003). Therefore, when the individual inhales, HR increases, BP falls, and the baroreflex
response results in a further increase in HR; on the contrary, when the individual exhales, HR
decreases, BP rises, and due to baroreflex activity, there is a further decrease in HR (Lehrer et
al., 2003). Hence, researchers have determined that HRV BFB training, through paced breathing
at one’s resonant frequency, produces resonance in the cardiovascular system, evokes highamplitude HR oscillations, and stimulates and exercises the baroreflexes, thereby improving
modulation of autonomic activity (Lehrer et al., 2000). McGrady (2007) suggested that the
magnitude of an individual’s HRV signifies one’s ability to adapt to physiological and emotional
changes due to HRV reflecting several mechanisms working together to maintain a sufficient
level of cardiovascular activity. Therefore, Wheat and Larkin (2010) suggested that HRV BFB
training may strengthen an individual’s ability to manage stress through increased HRV.
In addition to the physiological mechanisms by which HRV BFB may produce
improvements in HRV and a greater autonomic balance, thereby leading to beneficial effects,
researchers have proposed a number of alternative mechanisms through which HRV BFB could
yield beneficial effects and positive psychological outcomes (Karavidas et al., 2007; Hassett et
al., 2007; Wheat & Larkin, 2010). Paul and Garg (2012) suggested that HRV BFB training is a
self-regulatory intervention, which may contribute to reductions in psychophysiological stressors
and support optimal performance. Further, Hassett et al. (2007) proposed that beneficial effects
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seen through HRV BFB training may be a result of psychosocial processes rather than through
solely physiological mechanisms. Specifically, it was suggested that HRV BFB may produce
effects through experiences of relaxation, stress reduction, and the individual being provided
with the chance to become an active participant in treatment, which can enhance the patients
perceived level of control and self-esteem (Hassett et al., 2007). Karavidas et al. (2007)
proposed that other possible mechanisms of HRV training may include symptom amelioration
through increased attention to one’s breathing patterns and increased self-efficacy in selfregulation of mood states. Finally, Wheat and Larkin (2010) provided an explanation stating that
individuals may employ the techniques acquired through HRV BFB training when experiencing
an exacerbation of symptoms, which could explain clinical improvements without the
accompanying physiological changes. Therefore, beneficial effects of HRV BFB training may
result from the coping skills obtained, stress management techniques utilized, relaxation
strategies learned, and/or greater self-regulation achieved through increased awareness and
control over breathing and HR.
HRV BFB is an emerging area of interest within the field of psychophysiology, and due
to beneficial outcomes and encouraging results obtained in studies thus far; continued research
implementing HRV BFB is warranted. HRV methodologies have been shown to serve as a
viable treatment option for an array of health conditions and as a form of alternative therapy or
adjunct to more traditional medical interventions (Karavidas et al., 2007). For this form of
psychophysiological intervention, the benefits appear to outweigh the potential costs. HRV BFB
is noninvasive and safe with essentially no adverse side effects (Riganello, Garbarino, & Sannita,
2012). Further, BFB training and the related equipment is relatively inexpensive, the benefit/cost
ratio has been shown to be high, and it allows individualized therapy/feedback providing
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individuals with physiological information indicative of their own internal bodily rhythms
(Lehrer et al., 2000; Riganello, Garbarino, & Sannita, 2012). The following two sections will
include an overview of previous research using this form of BFB training with both clinical and
sport populations, respectively.
1.6 Clinical Applications of HRV BFB
Several modalities of BFB have been used in clinical populations as a form of adjunct
therapy to more traditional treatment options. HRV BFB, in particular, has been of particular
interest due to heart rate variability being an indicator of autonomic functioning and
cardiorespiratory balance. It is believed that a large number of chronic illnesses, both mental
health conditions and physiological disorders, can be attributed to dysfunction of the autonomic
nervous system (ANS). Further, it has been demonstrated that a number of the symptoms
associated with these chronic health conditions may be exacerbated by the imbalance between
sympathetic and parasympathetic activity of the ANS.
For example, Karavidas et al. (2007) investigated the effectiveness of HRV BFB in the
treatment of major depressive disorder (MDD). To date, treatments for depression have been
found to be costly, invasive, and with sub-standard outcomes. Through research, it has been
shown that reduced HRV has been linked to symptoms of depression, and this may be a
consequence of autonomic dysfunction resulting in a state of elevated sympathetic activity (as
cited in Karavidas et al., 2007). As such, the researchers in this study hypothesized that an
intervention targeting HRV in depressed patients may be effective as a treatment for symptom
reduction. Therefore, 11 individuals suffering from depression underwent ten weekly sessions of
HRV BFB, with physiological and psychological indices being assessed at baseline and weeks 4,
7, and 10. Findings indicated that HRV BFB training led to increased HRV within the depressed
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patients over the course of the weekly treatment sessions, and within sessions with LF HRV
being higher at the end compared to the beginning. In addition, heart rate was significantly
reduced in patients at the end of the treatment compared to before undergoing BFB therapy.
Lastly, depression severity and several neurovegetative symptoms of depression were
significantly improved upon. From the positive results obtained, it was concluded that HRV
BFB might be a feasible therapy option for treatment of depression, associated with improved
concentration and motivation, while reducing fatigue, loss of energy, and sleep disturbances
(Karavidas et al., 2007). However, due to the lack of a placebo and control condition, it cannot
be ascertained that the reduction in symptoms was due solely to HRV BFB and not instead
attributable to placebo effects or time passed.
Therefore, Siepmann, Aykac, Unterdörfer, Petrowski, and Mueck-Weymann (2008)
compared the effects of HRV BFB on autonomic function and mood in both depressed patients
and healthy subjects. The sample consisted of 14 depressed individuals and 12 healthy
participants who received 6-sessions of BFB with paced breathing over a 2 week duration. In
addition, another 12 healthy subjects were assigned to an active control condition, in which they
received BFB, but with no instruction or pacing stimulus. Subjective ratings of mood,
depression, and anxiety, in addition to HRV measurements, were administered at the beginning
of the treatment (baseline), post-intervention (two weeks), and at a follow up (two weeks later).
Findings demonstrated that depressed patients who received HRV BFB training significantly
increased their HRV from baseline to follow up. Further, depression symptoms and anxiety
levels were significantly reduced in the depressed patients during BFB and at follow up
compared to baseline. In contrast, no such findings were indicated in either of the two healthy
subject conditions, HRV BFB group or active control. This research was successful in providing
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additional evidence for HRV BFB’s efficacy as a treatment for depressive symptoms. The
researchers speculated that some of the benefits associated with BFB might have been obtained
through HRV BFB training inducing relaxed concentration and emotional self-regulation in
subjects (Siepmann et al., 2008).
Further, Zucker, Samuelson, Muench, Greenberg, and Gevirtz (2009) examined the
ability of HRV/ RSA BFB to serve as a treatment for Post-traumatic stress disorder (PTSD). The
researchers implemented an intervention where 38 participants were randomized into either a
RSA BFB group or a progressive muscle relaxation group (PMR) and received treatment
sessions over the course of four weeks. Assessments of PTSD symptoms, depression, insomnia,
and autonomic functioning were made pre-intervention and post-intervention. It was
hypothesized that patients in the RSA BFB condition would show greater improvements in
PTSD symptomology, reductions in depression scores, and increases in HRV compared to those
in the PMR group. Findings supported this hypothesis as the RSA BFB group reported
significantly greater reductions in depressive symptoms and subsequent increases in HRV.
However, both groups demonstrated significantly reduced PTSD symptoms and showed signs of
improvement in insomnia symptoms (Zucker et al., 2009). Hence, it seems as though HRV BFB
could be applied as an adjunctive therapy to standard treatments for a variety of psychiatric
illnesses. Also, it has the potential to serve as an intervention for improving upon traumatic
stress and a variety of other symptoms.
Researchers have also examined the effectiveness of HRV BFB in the treatment of
various chronic health conditions such as asthma, heart failure, coronary heart disease, and
fibromyalgia (Lehrer et al., 2004; Swanson et al., 2009; Del Pozo et al., 2004; Hassett et al.,
2007). Lehrer et al. (2004) applied HRV BFB to a group of asthma patients to determine if it
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could be used as an alternative treatment method, instead of relying solely on oral steroids and
more traditional pharmacological treatments. In this investigation, 94 asthma patients were
recruited and randomly assigned into one of four treatment conditions; a) a full protocol of HRV
BFB training with abdominal breathing through pursed lips with prolonged exhalation, b) HRV
BFB only, c) placebo EEG BFB, or d) a waiting list control group. Lasting ten weeks in
duration, patients’ daily asthma symptoms, expiratory flows, HRV, medication use, and asthma
severity levels were measured over the course of the intervention. Encouraging results were
obtained as both groups trained in HRV BFB demonstrated significantly greater reductions in
medication consumption than their control and placebo counterparts. In addition, HRV BFB
appeared to produce significant decreases in airway resistance, and respiratory frequency, while
increasing tidal volume and the patients’ HRV. Lastly, asthma symptoms and severity improved
an average of one full level for those in the HRV BFB and placebo groups. Hence, Lehrer et al.
(2004) concluded that HRV BFB could be used as a complementary therapy to reduce asthma
severity and that it might lower dependence on use of oral steroids.
In addition, Hassett et al. (2007) examined the effectiveness of HRV BFB for the
treatment of fibromyalgia and associated symptomology. It was suspected that HRV BFB may
have provided added benefits to patients suffering from fibromyalgia beyond helping them with
relaxation/stress management. This study consisted of recruiting 12 women who all suffered
from fibromyalgia, and were given the treatment option of completing 10 weekly sessions of
HRV BFB. In order to determine if HRV BFB was an efficacious, alternative treatment for
fibromyalgia patients, physiological and questionnaire data (functioning, depression, pain, &
sleep quality) were collected at sessions 1, 10, and at a 3-month follow up. Findings were
positive in nature and it appears through HRV BFB training, the patients were able to
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significantly improve their overall functioning from baseline to 3-months follow up.
Additionally, patients were found to have significant reductions in depression symptoms and
self-reported pain. Lastly, although not significant, there seemed to be a trend indicative of
better sleep quality amongst the patients throughout the study. The results obtained in this study
provided evidence suggestive of HRV BFB’s potential as a successful treatment for
fibromyalgia, while also speaking to the possibility of HRV BFB being used in pain management
(Hassett et al., 2007).
Regarding the idea of implementing HRV BFB as a treatment for pain management, there
have been clinical demonstrations of the effectiveness of this intervention for the treatment of
patients with chronic low back pain (Kapitza, Passie, Bernateck, & Karst, 2010), neck pain
(Hallman, Olsson, von Schéele, Melin, & Lyskov, 2011) and for children experiencing chronic
pain (Yetwin, 2012). Further, an intervention employing pain coping skills with those
undergoing knee arthroplasty was found to obtain encouraging results (Riddle et al., 2011).
Kapitza et al. (2010) implemented an intervention comparing the effects of a noncontingent respiratory BFB placebo group with a contingent BFB group in the treatment of
chronic low back pain. This study consisted of 42 patients with moderate chronic low back pain
who were randomized into either a BFB contingent group or a non-contingent placebo. The
experimental protocol consisted of both groups completing 30-minutes of respiratory BFB
training for 15 consecutive days, however, the pacing signal generated through the biofeedback
instrumentation was not synchronized with the patient’s breathing depth and frequency for those
in the placebo group. A variety of assessments were completed both prior to beginning the
intervention and upon completion of the treatment sessions. These consisted of relaxation
scores, pain measurements (i.e., pain diary, somatosensory profile, and psychopathology
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questionnaires), and daily functioning. When comparing results obtained between the two
groups, real respiratory BFB training was found to produce greater relaxation, reductions in pain
symptoms, and higher overall daily functioning (Kapitza et al., 2010).
Similarly, Hallman et al. (2011) examined the effectiveness of HRV BFB in the treatment
of chronic neck and shoulder pain. The researchers were also interested in HRV BFB’s potential
to improve upon the patient’s health-related quality of life, level of disability, stress, pain,
anxiety and depression symptoms. In this study, 24 patients were randomly assigned to either a
HRV BFB or control group, where those in the BFB condition received ten weekly sessions of
HRV BFB, while those assigned to the control group did not receive any prescribed treatment.
Findings demonstrated that those in the HRV BFB group achieved significantly greater increases
in LF HRV across sessions compared to their control counterparts. Also, health-related quality
of life indices (i.e., vitality, bodily pain, and social functioning) were significantly improved over
time in the HRV group (Hallman et al., 2011). Hence, it seems as though HRV BFB could be
implemented as a psychophysiological intervention to help individuals manage their pain and
learn effective coping techniques to aid in pain tolerance.
1.7 Sports Applications of HRV BFB
In the last decade, HRV BFB has been implemented as a psychophysiological
intervention in a wide variety of sports for performance enhancement and emotional regulation.
Many researchers have begun to examine the efficacy of BFB training as a potential mechanism
to improve psychomotor performance, as well as cognitive and psychological domains associated
with optimal performance outcomes. The application of psychological skills training and
subsequent research in the field has been around for some time, however, BFB has the distinct
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advantage of allowing athletes the opportunity to become aware of the interdependent
relationship which exists between the mind and body.
Bar-Eli, Dreshman, Blumenstein, and Weinstein (2002) investigated the relationship
between mental training with BFB and performance of young swimmers. In this study, the
researchers randomized 38 youth, competitive swimmers from two clubs into either an
experimental or control group. The experimental group underwent the first three phases of the
Wingate five-step mental training program with biofeedback, in addition to their regular training,
over the duration of the 14-week study. This entailed introducing the athletes to self-regulation
techniques, providing them with training using a BFB modality and finally, incorporating BFB
training with simulated competitive stress (Bar-Eli et al., 2002). The control group was only
provided with relaxation strategies and told to continue their regular training for the course of the
study. Bar-Eli and colleagues (2002) found that the experimental group achieved significantly
greater improvements in their swimming performance, with faster race times than their control
group counterparts. This led to the conclusion that mental training with BFB was advantageous
to swimmers, and provided added training benefits over regular physical conditioning alone
(Bar-Eli et al., 2002).
Further, Raymond, Sajid, Parkinson, and Gruzelier (2005) were concerned with
optimizing dance performances of 24 ballroom and Latin dancers. Participants, all of whom
were dancers on a college dance team, were randomly assigned to heart rate variability
biofeedback, alpha-theta neurofeedback, or a no treatment control group. It was hypothesized
that the two experimental conditions would both impact the dancers’ performances in a positive
manner, however the researchers believed that the effects would be associated with different
performance criteria. The dancers in both of the experimental conditions received ten sessions of
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BFB training, which lasted roughly 20 minutes in duration. Findings provided evidence that
both neurofeedback and heart rate variability biofeedback improved dance performance, when
compared to a no treatment control condition. In addition, results indicated that those in the
neurofeedback group achieved improvements in their timing, whereas biofeedback was shown to
improve the subscale of technique (Raymond et al., 2005). This research provided additional
evidence suggesting the effectiveness of biofeedback for performance enhancement, and
recommended its use alongside more conventional psychological interventions, such as guided
imagery and relaxation training, in sport (Raymond et al., 2005).
A case study conducted by Lagos et al. (2008) implemented HRV BFB with a 14-yearold elite golfer to examine its effects on his mood, physiology, and subsequent performance on
the golf course. More specifically, Lagos et al. (2008) were interested if HRV BFB could be
used as a strategy for helping young athletes to gain control of their emotions and regulate
competitive anxiety. The golfer in this particular study expressed concern and trouble dealing
with stress and anxiety while competing and described frequently experiencing adverse
physiological symptoms associated with his negative emotional states (increased heart rate,
sweating, trouble breathing, etc.). In attempts to provide a beneficial mental skills training
intervention for the athlete, researchers implemented 10 weekly sessions of HRV BFB with the
participant. Findings were positive in nature and demonstrated successful outcomes in terms of
psychological states, physiological functioning, and golf scores. The subject expressed a
dramatic improvement in feelings of depression, fatigue, anger, and anxiety after undergoing the
BFB training. Further, his total HRV and LF HRV increased during BFB training, in addition to
his HF HRV, LF HRV, and total HRV improving across the sessions from baseline to
completion of the treatment. Improvements seen both psychologically and physiologically may
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have assisted in his enhanced performance on the golf course, where he drastically reduced his
score. Overall, the results obtained in this study revealed that HRV BFB could be used to assist
athletes with their mental game, giving them that important psychological edge associated with
competition success. However, due to being implemented with only one athlete, the researchers
stated that future directions would entail applying HRV BFB with a larger sample size, varying
ages, skill levels, and with a range of sports (Lagos et al., 2008).
Paul, Garg, and Sandhu (2012) examined the effects of HRV BFB on psychomotor and
performance skills in basketball players. The investigation was found to have several strengths
rooted in its experimental protocol and methodology, consisting of random assignment to
conditions, a placebo and control group, double-blinded design, and a follow-up session.
Participants recruited for this study were 30 basketball players who competed at the university,
state, and national level. Athletes included were between the ages of 18-28 years old, and were
of mixed gender. Participants assigned to the HRV BFB condition received ten sessions of HRV
BFB training, lasting 20 minutes in duration each. Those who were allocated to the placebo
condition were shown motivational video clips for ten minutes daily on ten consecutive days.
Lastly, there was a control group condition, in which the athletes did not receive any additional
training, and simply continued their routine practice schedule. The dependent variables were
assessed pre-intervention (day 1), post-intervention (day 10), and at a 1-month follow up and
consisted of psychological, physiological, and performance measures. All three groups were
found to exhibit improvements in concentration, reaction time, movement time, and shooting
performance. However, the HRV BFB group demonstrated significantly greater concentration,
improved shooting performance, and faster movement times compared to those in either the
placebo or control groups. In addition, findings indicated that while all three groups showed
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improvements in respiration rate, total HRV, LF HRV, and HF HRV over the duration of the
intervention, lowered respiration rates and increases in heart rate variability were significantly
greater in the HRV BFB group. Within the HRV BFB group, total and LF HRV increased at the
end of BFB training sessions, whereas HF HRV was seen to decrease post training. From the
findings, Paul and colleagues concluded that HRV BFB facilitated athletes in achieving a state of
mental readiness, enhanced their ability to combat stress, and provided them with a better
understanding of how to focus and concentrate in a competitive setting (Paul et al., 2012). This
study was successful in further demonstrating the efficacy of HRV BFB for performance
enhancement, while also speaking to its effectiveness in helping athletes to regulate and control
stress and anxiety associated with competition.
Similarly, Paul and Garg (2012) applied HRV BFB to 30 male and female basketball
players who competed at a university, state, and/or national level. As with previous research, the
purpose of this investigation was to explore the effectiveness of HRV BFB on the performance
psychology and emotional self-regulation of anxious basketball players. The experimental
protocol and design methodology implemented for this study was comparable to the previous
research by Paul et al., (2012). A double-blinded study design, randomization into conditions,
inclusion of both placebo and control groups, and a 1-month follow up were all seen as strengths.
Participants were randomly assigned to one of three groups; a HRV BFB group that received
biofeedback training for 10 consecutive days, a placebo group who were shown motivational
video clips for 10 days, or a control group who received no additional training. Again,
dependent variables consisting of psychological measures (anxiety, coping self-efficacy),
physiological measures (HRV, respiration rate), and performance measures (dribbling, passing,
shooting) were assessed at baseline (Day 1), post-intervention (Day 10), and at a 1-month follow
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up. Findings indicated that the HRV BFB group exhibited significant improvements in the
psychological, physiological, and performance measures over the course of the intervention.
Further, those in the HRV BFB group were seen to produce significantly greater improvements
in anxiety, basketball performance skills (shooting, passing, dribbling), respiration, and HRV
compared to those in the placebo and control groups. In terms of coping self-efficacy, both the
placebo and HRV BFB group achieved increases, and while not demonstrating statistically
significant inter-group differences, the BFB group did seem to have greater coping scores.
Through the observed findings, the researchers discussed the dynamic relationship that seems to
exist between BFB training and improvements in self-efficacy and coping, which may help the
athletes in dealing with adverse emotional states such as stress and anxiety. It was concluded
that training in HRV BFB provides the potential for self-regulation of arousal states, reduction of
psychological stressors, and performance optimization (Paul & Garg, 2012).
1.8 Potential for HRV BFB Interventions in the Athletic Injury Population
Overall, it appears that the use of biofeedback, specifically HRV BFB, is an area of
particular interest within the realm of psychophysiology. Researchers have been successful in
demonstrating its effectiveness in both clinical populations and in the sport environment.
Findings have been positive in nature and have served to advocate for further investigations
surrounding HRV BFB. Although shown to be beneficial in a wide array of populations,
research regarding the use of HRV BFB could be regarded as being in its preliminary stages,
with much work to be done until its use, effects, mechanisms by which it operates, and full
potential are fully understood. Research completed to date has indicated that HRV BFB is a
promising psychophysiological intervention. In terms of its use in sport, HRV BFB has been
implemented for performance enhancement and performance psychology. Research has
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demonstrated its efficacy for creating self-regulation of mood states for optimal performance,
enhancing relaxation while reducing stress and anxiety, and for creating awareness of the
interdependent relationship existing between an athlete’s physiological symptoms and their
subsequent psychological state. In clinical populations, research has shown the potential of HRV
BFB to serve as an adjunct treatment for a wide range of medical conditions and chronic
illnesses associated with autonomic dysfunction. In this setting, HRV BFB interventions have
been implemented as a means to improve upon autonomic dysfunction and with the goal of
symptom reduction. However, this form of psychophysiological skills training has yet to be
extensively researched as a form of intervention to facilitate the injured athlete during their
rehabilitation process. More specifically, as a means to reduce the negative affect and emotional
distress experienced by injured athletes, while enhancing psychological traits seen to be
beneficial to a successful recovery with optimal outcomes, both physical and psychological.
Paul et al. (2012) stated that HRV BFB has the potential to create an “optimal tuning
between physiological, psychological, and psychomotor processes of the human body” (p. 39).
Additionally, Paul and Garg (2012) concluded that HRV BFB could be used in the area of sport
psychophysiology for purposes of emotional and cognitive restructuring. Biofeedback offers a
distinct advantage of providing individuals with physiological information indicative of their
own internal bodily rhythms to aid them in relaxation, help them to self-regulate physiologically,
and ultimately, allow them to cope better when faced with stressors. In both clinical and sports
populations, HRV BFB has been shown to enhance positive psychological states (relaxation,
concentration, coping, self-efficacy) while reducing negative symptoms (anxiety, stress, fatigue).
Injured athletes have been shown to experience similar emotions and mood states as a depressed
individual with high anxiety and a negative mood disposition (Appaneal et al., 2009). Again,
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HRV BFB training has been shown to enhance physiological functioning, reduce depressive
symptoms, and improve anxiety. Injured athletes could benefit from learning how to control and
manage their mood states better, which is a beneficial result that has been found through BFB
training. Consequently, HRV BFB could hold significant promise for interventions with injured
athletes given its demonstrated efficacy for enhancing self-regulation of mood states and
improving upon symptomatology in these other populations. Furthermore, BFB has been used as
a therapy in helping to treat pain and improve pain management, with promising results. In light
of these findings, it is possible that HRV BFB can also be used in the athletic injury setting as a
strategy to help athletes reduce pain catastrophizing and improve their management of perceived
pain.
1.9 Purpose
Given the genesis of the research study to evaluate the effectiveness of HRV
biofeedback, a form of psychophysiological skills training intervention, to improve athletes’
psychological response following an injury, the purpose was to examine the effects of HRV BFB
training on self-efficacy, perceived stress and anxiety, pain management, and the psychological
responses of injured athletes. HRV BFB effects on athletes’ physiological indices including
HRV, HR, and respiration rate were also assessed.
1.10 Hypotheses
Hypothesis 1. It was hypothesized that injured athletes who received the HRV BFB
intervention would demonstrate significantly greater improvements in psychological outcomes
pertaining to injury and rehabilitation across time than injured athletes who were not provided
with this form of intervention (i.e., HRV BFB Placebo group and Control group). Specifically, it
was hypothesized that the HRV BFB Experimental group would report significantly greater
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increases in perceptions of self-efficacy and reorganization, significantly greater decreases in
perceived stress, anxiety, and pain, significantly greater reductions in psychological responses of
devastation, feeling cheated, restlessness, and isolation, and finally, significantly greater declines
in pain catastrophizing and disability due to pain over time, compared to both the HRV BFB
Placebo group and Control group.
Hypothesis 2. It was hypothesized that injured athletes who received the HRV BFB
intervention would demonstrate significantly greater improvements in physiological indices
corresponding to BFB training than injured athletes who were not provided with this form of
intervention (i.e., HRV BFB Placebo group and Control group). Specifically, it was
hypothesized that the HRV BFB Experimental group would demonstrate significant increases in
both time-domain (e.g., SDNN) and frequency-domain (e.g., Total HRV, LF HRV, HF HRV)
measures of HRV, and significant declines in HR and respiration rate over the duration of the
study, compared to both the HRV BFB Placebo group and Control group.
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Chapter 2: Methods
The following chapter will describe the (a) participants who were recruited to take part in
the current investigation, (b) research design, (c) study procedures, (d) intervention delivery, (e)
measures used, and lastly (f) equipment and technical procedures.
2.1 Participants
Eligibility criteria. Participants recruited for this study were individuals who had
sustained a moderate to severe musculoskeletal sports injury (Fuller et al., 2006), preventing
their participation in training and competition for their respective sport. A moderate sports
injury is classified as an injury with 8-28 days elapsing from the date of injury to the date of the
player’s return to full participation in team training and competition. A severe sports injury is
classified as an injury, which may extend up to 428 days from the date of injury to the date of the
player’s return to full participation in team training and competition (Fuller et al., 2006).
Eligibility criteria included: (a) participants to be at least 16 years of age, (b) injuries to have
occurred during participation in sport/athletic activity, (c) participants to be out of practice and/or
competition for the sport in which the injury occurred, (d) participants to be undergoing
rehabilitation for the injury (e.g., physiotherapy, massage therapy, athletic therapy) and (e)
participants to be athletes involved in sport at a competitive level (e.g., regional, rep, varsity,
provincial, national) and/or to be engaging in sport in a competitive environment (e.g., adult
competitive league, training for specific events, road races, competitions, etc.). Exclusion
criteria included any volunteers with known medical disorders and/or heart abnormalities (e.g.,
cardiac arrhythmia) that would impede them from performing the biofeedback procedures.
Volunteers were excluded from study participation if they had a history/current diagnosis of
psychosis, coronary artery disease, heart disease, heart failure, hypertension, chronic low blood
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pressure, and/or kidney disease. Volunteers receiving formal training in any form of relaxation,
biofeedback, or breathing technique, and/or any volunteers receiving another psychological
intervention of any kind were also excluded. Eligibility criteria were assessed by way of selfreport through a recruitment email and subsequently a demographics questionnaire at baseline.
Sample. Participants were 32 athletes who had sustained a moderate to severe
musculoskeletal sports injury, met eligibility criteria, and agreed to participate. Due to four
participants withdrawing from the study, the final sample was 28 (see Figure 1). Participants
ranged in age from 18 to 36 years (Mage = 20.82, SD = 3.41), with a greater distribution of males
(n = 19; 67.9%) than females (n = 9; 32.1%). The sport/athletic activity in which the injury
occurred varied among the participants with eight different sports being cited. The
sports/athletic activities reported and number of participants whose injuries occurred in each
were as follows: soccer (n = 8), football (n = 6), hockey (n = 6), rugby (n = 4), baseball (n = 1),
basketball (n = 1), cheerleading (n = 1), and ultra-marathon running (n = 1). At the time of
injury onset, all participants were athletes involved in sport at a competitive level, majority being
university varsity athletes (n = 25), but also including a provincial junior B athlete (n = 1), and
competitive recreational athletes (e.g., adult competitive league, training for specific events) (n =
2). Types of injuries (i.e., location on body) sustained by participants included the knee (anterior
or posterior cruciate ligament, medial or lateral collateral ligament, meniscus; n = 12), hip (n =
5), ankle (n = 5), shoulder (dislocations; n = 2), and other (fractured fingers, groin strain,
sprains; n = 4). 78.6% of participants (n = 22) had a previous history of athletic injury, with
25% (n = 7) reporting four or more previous injuries, 21.4% (n = 6) reporting three, 14.3% (n =
4) reporting two, and 17.9% (n = 5) reporting one, while only 21.4% (n = 6) reported never
having sustained an injury before and/or no prior injury history. At time of recruitment,
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participants were at varying stages of their rehabilitation, however, all participants were out of
training and competition for their respective sports and engaged in a rehabilitation program. For
a complete overview of participant demographic information, see Table 1.
2.2 Research Design
This investigation was experimental in nature with a randomized, single-blinded study
design. A 4 (Time: Baseline, Week 1, Week 2, Week 3; assessments across time) x 3 (Group:
HRV BFB Experimental group, HRV BFB Placebo group, Control group; experimental
conditions) mixed model design was utilized to examine the emotional experience and
psychological responses of injured athletes as they progressed through injury recovery. Different
groups were required in order to evaluate if athletes' psychological responses regarding injury
and rehabilitation differed depending on the specific training they received. Specifically, there
was an experimental group, which received the allocated intervention, in order to examine the
effects of HRV BFB on injured athletes’ psychological responses post-injury. A placebo group
was included in order to control for any expectancy effects (e.g., attention, social support, etc.)
and to allow the researchers to differentiate between these and true training effects. Finally, a
control group to determine if either of the above conditions produced effects different from
receiving no treatment at all was included.
2.3 Study Procedures
Recruitment methods. Injured athletes were recruited as study participants from varsity
athletics programs at Wilfrid Laurier University via the athletic therapy clinic and from three
clinics specializing in athletic injury rehabilitation in the Kitchener-Waterloo vicinity. Head
athletic therapists, sport medicine doctors, and physiotherapists at these locations were informed
regarding the study details and provided with a letter of information (see Appendix A). All of
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these individuals were gracious enough to assist with study recruitment by way of notifying any
clients who may have met eligibility criteria of potential study participation. Recruitment posters
(see Appendix B) and participant letters of information (see Appendix C) were utilized to inform
potential participants of the study parameters at these locations. For study purposes (i.e., due to
there being three separate experimental groups), the initial recruitment posters and information
letters only partially disclosed the study objectives to potential participants. Having frequent and
on-going communication with the head athletic therapists (ATs) for Wilfrid Laurier varsity
athletics, face-to-face introduction often served as a primary recruitment tool. After being
introduced by the ATs, the potential participant would be provided with a brief introduction to
the study requirements and a letter of information. If interested in study participation, injured
athletes completed a tear-off section on the letter of information on which the candidates’ name,
injury, email, and phone number was given. At this point, potential participants would be sent a
recruitment email screening for eligibility (see Appendix D). A second example of recruitment
was when face-to-face introduction did not occur, but rather the ATs provided the letter of
information and obtained the injured athletes contact information, passing it on to the researcher,
Scott Rollo, with the athlete’s consent. At this point, potential participants would be sent a
recruitment email screening for eligibility. Finally, a third example of recruitment was when
interested individuals contacted the researcher themselves after viewing the recruitment poster
and/or being given the letter of information, at which point they were screened for eligibility.
Protocol. If deemed eligible for study participation, volunteers were randomly assigned
to one of three groups; A) HRV BFB Experimental Group (i.e., full protocol with abdominal
breathing through pursed lips and prolonged exhalation), B) HRV BFB Placebo Group, or C)
Control Group (i.e., no treatment). Randomization was implemented by way of randomly
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selecting one of three group tags out of a hat for each participant who showed interest and met
eligibility criteria. A baseline (pre-intervention) visit would then be arranged, in which eligible
participants were thoroughly informed regarding study details (e.g., purpose, assessments,
protocol, etc.), and provided with an informed consent (applicable to their assigned group; see
Appendix E-G) to complete if they wished to proceed with study participation. After signing and
providing informed consent, the participant was asked to complete a demographics
questionnaire, followed by self-report questionnaires for baseline measurement of psychological
outcome variables. Those participants assigned to either the intervention or placebo groups were
then introduced to the setting, equipment, and basic procedures of biofeedback. Finally, a
psychophysiological assessment was administered to obtain the participants’ baseline
physiological data (i.e., HRV, HR, and respiration measures). During this assessment, roughly
20 minutes in duration, physiological data was recorded during two ten-minute tasks: 1) Task A
– rest period in which participants were asked to relax as much as possible, and 2) Task B – a
paced breathing exercise. For the paced breathing task, participants were instructed to utilize the
biofeedback information provided on the computer screen and match the rhythm of their
breathing to a slowly oscillating respiratory pacer, set at six breaths-per-minute. During the
baseline session pre-intervention, meeting times for corresponding training sessions and weekly
assessments were arranged according to the participants schedule and availability.
Those participants assigned to the HRV BFB group received six BFB training sessions,
involving instruction in paced breathing at one’s resonant frequency and with the goal of
maximizing HRV, over the course of three weeks (approx. two sessions per week). Participants
randomized into the Placebo group also received six BFB training sessions over the three-week
duration (approx. two sessions per week), however these individuals were not instructed to
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breathe in a paced way or to maximize their HRV. Individuals in this group still received the
same on-screen physiological information through biofeedback, however, they were provided
with no additional information, other than to relax and continue their normal breathing pattern.
Participants randomly assigned to the Control group received no training of any kind over the
duration of the study. In order to increase session attendance and provide a form of incentive, all
participants were given a $10.00 gift certificate to Tim Hortons at study completion.
In addition to data collection during the baseline assessment, psychological outcome
questionnaires and the psychophysiological assessment were administered at Week One (i.e., day
eight), Week Two (i.e., day 15), and Week Three (i.e., post-intervention, day 22) (see Figure 2
for an illustrated overview of the research protocol). All biofeedback training and data collection
sessions were conducted in the Physiology laboratory in the Athletic Complex at Wilfrid Laurier
University, with an ambient room temperature (20° C - 25° C) and sound attenuation. The study
protocol was approved by the Research Ethics Board at Wilfrid Laurier University (see
Appendix H), and written informed consent was obtained from all participants. Upon study
completion, all participants were debriefed and provided with an explanation as to what the true
purpose of the study was (see Appendix I). Importance of the initial deceit upon study
recruitment was justified and why this was necessary to obtain meaningful results was explained.
2.4 Intervention
HRV BFB experimental group. Participants randomized into the HRV BFB group
received six HRV BFB training sessions over the course of three weeks (approximately two per
week), lasting roughly 30 minutes in duration. The protocol designed by Lehrer et al. (2000) for
HRV BFB training was implemented with these participants. The BFB training sessions
involved instruction in paced breathing at one’s resonant frequency with a specific emphasis on
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maximizing HRV. At the beginning of each session, the participant was asked to sit with their
eyes closed in a semi-reclined position for five-minutes while attempting to relax and breathe
normally. After the initial resting period, allowing for the participant to get settled and clear
their mind of any ‘noise’, participants were provided with 20 minutes of HRV BFB training. In
the first session, the participants were taught to breathe at their resonant frequency. The resonant
frequency was determined by asking the participant to breathe at variable respiratory rates for 2
minutes each (6.5, 6.0, 5.5, 5.0, 4.5 breaths/minute). A “pacing stimulus” was provided on the
computer screen to aid the participant in this task. The resonant frequency was identified as the
respiratory frequency yielding the highest low-frequency HRV on the moving Fourier power
spectrum displayed by the AD Instruments LabChart Pro 7.0 BFB software. Participants were
then asked to practice breathing at their respective resonant frequency and to relax. In
subsequent sessions, the participants were trained how to breathe using pursed lips, abdominal
breathing techniques with prolonged exhalation in order to elicit high amplitude oscillations in
HR at their resonant frequency. Participants were provided with BFB (i.e., physiological data) in
numerous forms. Utilizing the physiological data displayed (e.g., beat-to-beat heart rate display,
respiratory activity, and respiratory pacer), participants were instructed to increase the amplitude
of heart rate oscillations that occur in phase with respiration. Through providing these
individuals with a HRV BFB training protocol and HRV biofeedback, the goal was to teach
participants to self-regulate by increasing their awareness and control over their breathing and
HR.
In addition to in-session training, participants were instructed and encouraged to practice
breathing at their resonant frequency for 20 minutes daily outside of training (e.g., at home,
and/or when feeling stressed, etc.). Participants could engage in this practice using a clock
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and/or timer, or with the use of a respiratory pacer via a downloadable application available for
many Smartphones. More in-depth details of the training protocol for HRV BFB can be found in
Lehrer et al. (2000). Participants in this group were also asked to attend four data collection
sessions (i.e., Baseline, Week One, Week Two, and Week Three). Scheduling of these
assessments occurred during the initial baseline session carried out pre-intervention. During data
collection sessions, these participants were asked to complete psychological outcome
questionnaires and the psychophysiological assessment.
HRV BFB placebo group. Participants randomly assigned to the Placebo group also
received six BFB training sessions over the three-week duration (approx. two per week), lasting
roughly 30 minutes in length. However, the BFB training sessions for these participants did not
involve instruction in paced breathing at one’s resonant frequency or techniques to maximize
HRV. At the beginning of each session, the participant was asked to sit with their eyes closed in
a semi-reclined position for five-minutes while attempting to relax and breathe normally. After
the initial resting period, allowing for the participant to get settled and clear their mind of any
‘noise’, participants were provided with 20 minutes of BFB. Participants in this group still
received the same on-screen physiological information through BFB, however, they were
provided with no additional information, other than to relax and continue their normal breathing
pattern. Participants in this group were also asked to attend four data collection sessions (i.e.,
Baseline, Week One, Week Two, and Week Three). Scheduling of these assessments occurred
during the initial baseline session carried out pre-intervention. During data collection sessions,
these participants were asked to complete psychological outcome questionnaires and the
psychophysiological assessment.
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Control group. Participants randomly assigned to the Control group received no training
of any kind over the duration of the study. Participants in this group were only asked to attend
data collection sessions (i.e., Baseline, Week One, Week Two, and Week Three). Scheduling of
these assessments occurred during the initial baseline session carried out pre-intervention.
Completion of psychological outcome questionnaires and the psychophysiological assessment
were the only tasks requested of these participants.
2.5 Measures
Demographic information. All participants were asked to complete a demographics
questionnaire (see Appendix J) that assessed background information including name, age, sex,
history of athletic injuries, sporting involvement, the sport/athletic activity in which the present
injury occurred, level of competition, current injury, time since injury, estimated time to return to
play, and type of injury rehabilitation.
Self-efficacy. The Athletic Injury Self-Efficacy Questionnaire (AISEQ; Milne et al.,
2005; see Appendix K) was used to assess the athlete’s self-efficacy for rehabilitation. The
AISEQ is composed of seven items that represent two types of self-efficacy; task self-efficacy
and coping self-efficacy. An example of a task item would be “I am confident that I can perform
all of the required rehabilitation exercises.” An example of a coping item is “I am confident that
I can do my rehabilitation exercises even though I am feeling some discomfort.” A scale ranging
from 0% (no confidence) to 100% (completely confident) was used by participants to rate their
perceived level of self-efficacy. The AISEQ has demonstrated sound psychometric properties
and reliability has been found to be acceptable (alphas: task efficacy = .76-.95, coping efficacy =
.79-.90).
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Perceived stress. The Perceived Stress Scale-10 (PSS-10; Cohen, Kamarck, &
Mermelstein, 1983; see Appendix L) was used to assess the degree to which situations in an
individual’s life are appraised as stressful. The PSS-10 is a 10-item questionnaire, which is
designed to tap how unpredictable, uncontrollable, and overloaded respondents find their lives.
Items are measured on a 5-point Likert scale, in which participants are asked to indicate how
often they have felt or thought a certain way (0=never, 1=almost never, 2=sometimes, 3=fairly
often, 4=very often). The standard response time frame used in the current study was “In the last
week . . .” Example items on the PSS-10 are “how often have you felt nervous and “stressed””
or “how often have you been angered because of things that were outside of your control?” The
PSS-10 has adequate internal reliability with a Cronbach’s coefficient alpha = .90.
Psychological responses to sport injury. Participants’ psychological responses to athletic
injury were assessed using the 19-item Psychological Responses to Sport Injury Inventory
(PRSII; Evans, Hardy, Mitchell, & Rees, 2008; see Appendix M). The PRSII measure is
comprised of five subscales; devastation (i.e., reflects feelings of intense shock and emptiness),
feeling cheated (i.e., reflects bitterness at being injured), restlessness (i.e., characterized by
feelings of anxiety, guilt, and hostility), reorganization (i.e., represents increased confidence and
a sense of psychological recovery), and isolation (i.e., represents feelings of isolation). Items are
measured on a 5-point Likert scale anchored at 5 (strongly agree) and 1 (strongly disagree).
Each subscale score (with the exception of reorganization) ranges from a low of 4 to a high of
20. For reorganization, this equates to a low of 3 and a high of 15. Example items on the PRSII
are, “I feel as if I have been cheated by being injured” and “I am unusually anxious.” Evans et
al. (2008) provided evidence of content and predictive validity. Cronbach’s alpha coefficients
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averaged over the time phases of injury were .82 for devastation, .75 for reorganization, .77 for
feeling cheated, .85 for restlessness, and .72 for isolation.
Anxiety. The State-Trait Anxiety Inventory (STAI; Spielberger, Gorsuch, & Lushene,
1970; see Appendix N) was used to measure anxiety in the athletes. The STAI is a self-report
questionnaire, comprised of 40-items, which are measured on a 4-point Likert scale (1=not at all,
2=a little, 3=somewhat, 4=very much so). Consisting of two subscales, the STAI includes 20
items to assess trait anxiety, and 20 items to assess situational anxiety. For purposes of this
study, only the items representing the state anxiety subscale were used. The STAI has
demonstrated test-retest correlations for the Trait Scale ranging from .73-.86, and for the State
Scale ranging from .16-.54. Reliability coefficients for the Trait Scale range from .86-.92, and
for the State Scale range from .83-.92.
Pain management. The Pain Catastrophizing Scale (PCS; Sullivan, Bishop, & Pivik,
1995; see Appendix O) was used to assess the athletes’ level of pain catastrophizing through the
degree to which various thoughts and feelings surrounding pain are experienced. The PCS was
designed to capture the extent of a patient’s negative or exaggerated orientation to pain and it
addresses primary constructs of rumination, magnification, and helplessness (Sullivan et al.,
1995). The PCS is a 13-item questionnaire with items being ranked using a 5-point scale,
ranging from 0 (not at all) to 4 (all the time). Examples of items on the PCS are “when I’m in
pain, it’s terrible and I think it’s never going to get any better,” or “when I’m in pain, there is
nothing I can do to reduce the intensity of the pain.” The PCS has been demonstrated to have
adequate to excellent internal consistency (coefficient alphas: total PCS = .87, rumination = .87,
magnification = .66, and helplessness = .78).

HEART RATE VARIABILITY BIOFEEDBACK

39

Athletes’ subjective experience of pain during rehabilitation was measured using the
Visual Analogue Scale (VAS; Keefe, Brown, Scott, & Ziesat, 1982; see Appendix P), which
requires participants to rank the level of pain experienced on a 10-point scale ranging from “no
pain” to “pain as bad as it could be”.
Additionally, the impact of pain on daily functioning was evaluated through the use of
the Pain Disability Index (PDI; Tait et al., 1987; Tait et al., 1990; see Appendix Q). The PDI
was designed to measure the degree to which aspects of life are disrupted by pain and disability.
This questionnaire consists of seven subscales, each of which represents a different area of
functioning: (a) family/home responsibilities, (b) recreation, (c) social activity, (d) occupation,
(e) sexual behavior, (f) self-care, and (g) life support activity. For each subscale, an 11-point
scale ranging from 0 (no disability) to 10 (worst disability) measures the impact of pain and
overall disability. This index has shown a relatively high value for internal consistency (alpha =
.86).
Rehabilitation adherence. Athletes’ rehabilitation adherence was assessed using a
measure designed by Milne et al. (2005) (see Appendix R). Rehabilitation adherence was
evaluated in three ways: the frequency that rehabilitation exercises were undertaken, the duration
of these exercises, and the quality with which they were completed (Milne et al., 2005).
Frequency of exercise was measured with two questions: “How often does your physiotherapist
want you to do your rehabilitation exercises (e.g., once per day)?”, which indicates the
prescribed frequency, and “How often do you actually do your rehabilitation exercises?”, which
indicates the actual frequency. Similarly, exercise duration also was measured with two
questions: “How long (minutes) does your physiotherapist want you to spend on your exercises
each time you do them?” (i.e., prescribed) and “How long (minutes) do you actually spend on
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your exercises each time you do them?” (i.e., actual). The percentage scores for frequency and
duration of exercise were calculated by dividing the actual into the prescribed and multiplying by
100; a score greater than 100% indicated that participants performed their rehabilitation exercise
more frequently or for a longer duration than prescribed. Quality of exercise was measured with
one question: “What percentage (%) of the time do you believe that you perform your
rehabilitation exercises correctly?’’ Milne et al. (2005) obtained face validity from four
physiotherapists in the development phase of this adherence measure.
Psychophysiological assessment. Prior to meeting for data collection at each of the
weekly assessments, participants were reminded to refrain from caffeine, alcohol, eating large
meals and engaging in heavy exercise beforehand. For the psychophysiological assessment
during data collection sessions, participants were asked to sit in a semi-reclined position while
remaining comfortable and relaxed. The purpose of this assessment period was outlined for the
participant so they understood all instructions and the tasks being asked of them. After providing
any instruction required the respiration-monitoring belt, ECG sensors, and finger-pulse
transducer were attached to the participant in the appropriate locations (see Equipment and
Technical Procedures). During this assessment, roughly 20 minutes in duration, physiological
data was recorded during two ten-minute tasks: Task A – Rest Period and Task B – Paced
Breathing Exercise. For Task A, participants were instructed to relax as much as possible and
breathe normally (i.e., normal resting breathing pattern and/or however was most comfortable)
for a ten-minute period. Following this, the participant completed Task B, a paced breathing
exercise in which they were instructed to utilize the biofeedback information provided on the
computer screen and match the rhythm of their breathing to a slowly oscillating respiratory
pacer, set at six breaths-per-minute. For both the resting period and the paced breathing exercise,
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HRV time-domain and frequency-domain indices were calculated. SDNN, which is the standard
deviation of normal-to-normal intervals, was calculated. pNN50, which is the percentage of
successive normal inter-beat intervals which differ by 50 milliseconds (ms) or more, was also
calculated by dividing the NN50 count by the total number of all NN intervals. A spectral power
analysis was administered over each of the tasks by means of a fast Fourier transformation
(FFT). Total power (Total HRV), and power values for two frequency bands, low-frequency
(0.04-0.15 Hz; LF HRV) and high-frequency (0.15-0.4 Hz; HF HRV) were assessed. For both
tasks, the participants’ average heart rate (Mean HR; beats per minute) and average respiration
rate (breaths per minute) were calculated.
2.6 Equipment and Technical Procedures
All HRV BFB training sessions and psychophysiological assessments were administered
using an AD Instruments PowerLab 26T biofeedback unit with LabChart Pro 7.0 software and
the HRV module add-on (AD Instruments, Canada.). Physiological indices were measured and
amplified with the utilization of sensors, attached to participants via electrodes and a respiration
strap, which were connected to the AD Instruments PowerLab 26T encoder. The analogue to
digital converter transforms the electrical signals (i.e., voltage) to digital conversion points, and
physiological data is recorded into a computer to be processed, displayed, and analyzed by
specialized AD Instruments LabChart Pro 7.0 BFB software. During BFB training sessions and
psychophysiological assessments, respiration, HRV indices, and HR as measured by cardiac
activity (ECG) and pulse (beats per minute) were recorded. Respiratory patterns were collected
by use of a respiration-monitoring belt with sensors placed around the participant’s upper
abdomen (see Figure 3), digitized at a rate of 256 samples/second. HR and cardiac rhythm were
measured using ECG sensors, connected to the participant via three electrodes placed on the
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medial aspect of the participants’ forearms (one electrode placed on the right arm and two
electrodes placed on the left arm) (see Figure 4), using a sampling rate of 2048 samples/second.
HR was also calculated by way of a finger-pulse transducer inserted on the participant’s middle
finger. AD Instruments LabChart Pro 7.0 software offers numerous display screens for a variety
of training and data reporting purposes. The raw ECG signal, HR (pulse), instantaneous HR
(beats per minute), an RSA graph, respiration rate and a respiratory pacer (for Task B and/or
HRV BFB Experimental group training only) were presented to the participants during the
psychophysiological assessments and HRV BFB training sessions (see Figure 5 for an image of
the BFB display screen). Indices of HRV (frequency-domain and time-domain variables) were
calculated for data collection purposes. Specifically, the time-domain HRV values, SDNN and
pNN50, and frequency-domain values, LF HRV, HF HRV, and Total HRV were measured from
the psychophysiological assessment. All HRV raw data was edited before calculations were run
to measure HRV indices, consisting of normalizing the IBI data and removing any artifacts
within the recorded sessions. First, R-wave detection settings were adjusted to detect all genuine
beats by increasing the threshold enough to avoid unwanted peaks or “noise” in the sample or by
decreasing the threshold to detect genuine beats that were missed. If needed, beats were
manually inserted in cases where true beats were missed or in the instance of abnormally large
artifacts due to “noise” (i.e., equipment error). After editing, analyses for all HRV indices were
performed and values were entered into Microsoft Excel.
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Chapter 3: Results
The following chapter includes a summary of the overall findings based on the original
hypotheses. Specifically, the chapter describes the stages of analysis by examining (a) data
cleaning procedures and (b) statistical tests performed, followed by discussing (c) descriptive
statistics, and (d) baseline measurements, as well as testing the specific hypotheses surrounding
the influence of the HRV BFB intervention on (d) self-efficacy, (e) perceived stress, (f)
psychological responses to sport injury, (g) perceived anxiety, (f) pain management, and (g)
rehabilitation adherence. Hypotheses surrounding the influence of the HRV BFB intervention on
(h) physiological indices will also be tested.
3.1 Data Cleaning Procedures
Data analysis. Post data collection, all self-report psychological outcome questionnaires
completed by participants at each of the four assessments (i.e., Baseline, Week 1, Week 2, Week
3) were scored and values were entered into Microsoft Excel for each of the respective
dependent variables. With regards to the psychophysiological assessment, participants’
physiological indices were recorded during two ten-minute tasks (Task A & Task B) at each of
the four assessments, producing eight ten-minute recordings for each participant. As mentioned
previous, raw data for each recording was analyzed and all HRV data was edited consisting of
normalizing the IBI data and removing any artifacts within the recorded sessions. R-wave
detection settings were adjusted to detect all genuine beats, and if needed, beats were manually
inserted. After editing, analyses for all HRV indices were performed and values were entered
into Microsoft Excel. Participant’s average respiration rates for both tasks were calculated and
these were entered into Microsoft Excel.
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Removal of participants. Prior to data analysis, the removal of data from four
participants was carried out. Over the length of the study, there were four athletes who met
eligibility criteria and agreed to participate, but subsequently withdrew from participation prior
to study completion. Specifically, two participants from the HRV BFB Placebo group withdrew
from study participation after Baseline before Week 1, one participant from the HRV BFB
Experimental group withdrew prior to Week 1, and one participant from the Control group
withdrew prior to Week 1. One participant did not provide reasoning for withdrawing, two cited
time conflicts as a reason, and one cited personal reasons for doing so.
Dealing with missing data. During data entry, all missing data points were coded by
imputing a random numerical value (e.g., 200). The statistical analyses performed on the data
allowed for missing observations under a missing at random assumption. If a value for a
dependent variable was missing for a participant at one or more assessments, the participant was
subsequently excluded from the analysis for that variable.
3.2 Statistical Analyses
Statistical analyses were performed using the Statistical Package for Social Sciences
(SPSS) version 22.0. There were two independent factors incorporated into this study design.
The repeated-measures independent variable was data collection sessions (i.e., assessments
across time) and the between-group independent variable was the three experimental conditions
(i.e., group). An analysis of variance (ANOVA) with a 4x3 mixed-model design was conducted
for each dependent variable to assess for both within-subjects (i.e., Baseline, Week One, Week
Two, and Week Three) and between-subjects (i.e., HRV BFB Experimental Group, HRV BFB
Placebo Group, and Control Group) effects. Specifically, to test for differences between groups
across time with respect to psychological outcome questionnaire scores and psychophysiological
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assessment measures. Simple contrasts with Baseline as the reference category were run for
within-subjects time main effects and the time x group interaction. Follow-up Tukey tests were
run for the between-subjects main effect of group. A P value < .05 was regarded as significant.
Skewness and Kurtosis values by group were examined for each dependent variable across time
and revealed reasonably normal distributions given sample size and parameters. The assumption
of sphericity occurs in repeated-measures ANOVAs with more than two levels. Where
Mauchly’s test of sphericity was violated, the Huynh-Feldt correction was used for reporting pvalues.
3.3 Baseline Measurements
In order to assess for any group differences at Baseline pertaining to both the
psychological outcome questionnaire scores and psychophysiological assessment measures, a
series of one-way ANOVAS were conducted for each variable. These were mainly conducted
due to the realization that on a number of the psychological outcome variables, group means for
the HRV BFB Placebo group were noticeably different from either of the other two groups at
Baseline. From these analyses, although there were still concerns as to why the Placebo group
appeared to be different at Baseline on a number of variables, it was confirmed that there were
no statistically significant group differences other than for the psychological response to sport
injury subscale of devastation, F (2, 25) = 4.07, p < .05. For devastation, post-hoc Tukey tests
revealed that the Placebo group was significantly lower in levels of devastation than the HRV
BFB Experimental group at Baseline.
3.4 Self-efficacy
Task. Table 2 contains the group means and standard deviations for perceived task selfefficacy at Baseline, Week 1, Week 2, and Week 3, as measured by the AISEQ. Results of the
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analysis of task self-efficacy showed no significant main effect for time, indicating that task selfefficacy scores for all groups remained relatively the same across time from Baseline to Week 3,
F (2.22, 55.60) = 1.62, p = .21, η2 = .06. The 4x3 mixed design ANOVA results revealed no
main effect for group, indicating that there were no significant differences in task self-efficacy
between groups, F (2, 25) = 1.63, p = .22, η2 = .12. As can be seen by Figure 6, means for all
three groups suggest that participants had high task self-efficacy and that this persisted across
time for each group.
Coping. Table 2 contains the group means and standard deviations for perceived coping
self-efficacy at Baseline, Week 1, Week 2, and Week 3, as measured by the AISEQ. Results of
the analysis revealed a significant time main effect for coping self-efficacy, F (1.90, 47.41) =
5.40, p < .01, η2 = .18. Within-subjects contrasts showed a significant difference between
Baseline and Week 3 reflecting a significant increase in participants level of coping self-efficacy
between these two time phases, F (1, 25) = 4.98, p < .05, η2 = .17. There was no significant
Time x Group interaction found, F (3.79, 47.41) = .56, p = .68, η2 = .04. The 4x3 mixed design
ANOVA results showed no main effect for group, indicating that there were no significant
differences in coping self-efficacy between groups, F (2, 25) = 1.50, p = .24, η2 = .11. As can be
seen by Figure 7, means for all groups suggest that coping self-efficacy was relatively high
among participants at Baseline and further increased across time.
3.5 Perceived Stress
The means and standard deviations for perceived stress at Baseline, Week 1, Week 2, and
Week 3 for each of the three groups are shown in Table 3. Results of the analysis revealed a
significant time main effect for perceived stress, F (3, 75) = 5.95, p < .01, η2 = .19. Withinsubjects contrasts showed a significant difference between Baseline and Week 3 reflecting a
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significant decrease in participants level of perceived stress between these two time phases, F (1,
25) = 12.13, p < .01, η2 = .33. There was no significant Time x Group interaction found, F (6,
75) = 1.63, p = .15, η2 = .12. The 4x3 mixed design ANOVA results showed no main effect for
group, indicating that there were no significant differences in perceived stress levels between
groups, F (2, 25) = .92, p = .41, η2 = .07. As can be seen by Figure 8, groups means suggest that
perceived stress significantly decreased over time from Baseline to Week 3.
3.6 Psychological Response to Sport Injury
Devastation. Table 4 contains the group means and standard deviations for the
psychological response to sport injury subscale of devastation at Baseline, Week 1, Week 2, and
Week 3, as measured by the PRSII-19. Analyses of the subscales of the PRSII produced a
significant time main effect for devastation, F (3, 75) = 12.87, p < .001, η2 = .34. Withinsubjects contrasts revealed significant differences between Baseline and Week 1, F (1, 25) =
4.41, p < .05, η2 = .15, Baseline and Week 2, F (1, 25) = 12.42, p < .01, η2 = .33, and Baseline
and Week 3, F (1, 25) = 23.88, p < .001, η2 = .49, reflecting a significant decrease in participants
level of devastation across the time phases. Results of the analysis also produced a significant
Time x Group interaction, F (6, 75) = 5.84, p < .001, η2 = .32. This indicates that levels of
devastation at the different time phases differed between groups. To break down this interaction,
contrasts were performed comparing each of the weekly assessments to Baseline across groups.
These revealed significant interactions when comparing Experimental, Placebo, and Control
group levels of devastation at Week 1 compared to Baseline, F (2, 25) = 4.90, p < .05, η2 = .28,
Week 2 compared to Baseline, F (2, 25) = 6.63, p < .01, η2 = .35, and Week 3 compared to
Baseline, F (2, 25) = 10.84, p < .001, η2 = .46. Looking at the interaction graph, Figure 9, this
suggests that decreases in devastation from Baseline to Week 1, Week 2, and Week 3 found for
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the Experimental group were significantly greater than for either the Placebo or Control group.
The 4x3 mixed design ANOVA results showed no main effect for group, indicating that there
were no significant differences in levels of devastation between groups, F (2, 25) = .47, p = .63,
η2 = .04. As Figure 9 shows, although participants level of devastation decreased across time, it
can be concluded that this decrease was significantly more pronounced for those in the
Experimental group compared to those in either the Placebo or Control groups.
Reorganization. The group means and standard deviations for the psychological response
to sport injury subscale of reorganization at Baseline, Week 1, Week 2, and Week 3 are shown in
Table 4. Analyses of the subscales of the PRSII indicated a significant time main effect for
reorganization, F (3, 75) = 5.94, p < .01, η2 = .19. Within-subjects contrasts showed significant
differences between Baseline and Week 2, F (1, 25) = 5.01, p < .05, η2 = .17 and Baseline and
Week 3, F (1, 25) = 23.77, p < .001, η2 = .49, reflecting a significant increase in participants
level of reorganization across the time phases. Results of the analysis also produced a significant
Time x Group interaction, F (6, 75) = 2.73, p < .05, η2 = .18. This indicates that levels of
reorganization at the different time phases differed between groups. To break down this
interaction, contrasts were performed comparing each of the weekly assessments to Baseline
across groups. These revealed significant interactions when comparing Experimental, Placebo,
and Control group levels of reorganization at Week 1 compared to Baseline, F (2, 25) = 3.77, p <
.05, η2 = .23, Week 2 compared to Baseline, F (2, 25) = 3.61, p < .05, η2 = .22, and Week 3
compared to Baseline, F (2, 25) = 5.00, p < .05, η2 = .29. Looking at the interaction graph,
Figure 10, this suggests that increases in reorganization from Baseline to Week 1, Week 2, and
Week 3 found for the Experimental group were significantly greater than for either the Placebo
or Control group. The 4x3 mixed design ANOVA results showed no main effect for group,
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indicating that there were no significant differences in levels of reorganization between groups, F
(2, 25) = .56, p = .58, η2 = .04. As Figure 10 shows, although participants’ level of
reorganization increased across time, it can be concluded that this increase was significantly
more pronounced for those in the Experimental group compared to those in either the Placebo or
Control groups.
Feeling cheated. Table 4 contains the group means and standard deviations for the
psychological response to sport injury subscale of feeling cheated at Baseline, Week 1, Week 2,
and Week 3, as measured by the PRSII-19. Analyses of the subscales of the PRSII revealed that
there was no significant main effect of time on feeling cheated, indicating that overall,
participants levels of feeling cheated remained relatively the same across time from Baseline to
Week 3, F (2.25, 56.31) = .93, p = .41, η2 = .04. There was also no significant Time x Group
interaction found, F (4.51, 56.31) = 1.82, p = .13, η2 = .13. The 4x3 mixed design ANOVA
results showed no main effect for group, indicating that there were no significant differences in
levels of feeling cheated between groups, F (2, 25) = .33, p = .72, η2 = .03. As can be seen by
Figure 11, group means suggest that participants’ levels of feeling cheated remained relatively
stable over time from Baseline to Week 3.
Restlessness. The group means and standard deviations for the psychological response to
sport injury subscale of restlessness at Baseline, Week 1, Week 2, and Week 3 are shown in
Table 4. Analyses of the subscales of the PRSII revealed a significant time main effect for
restlessness, F (2.01, 50.36) = 6.32, p < .01, η2 = .20. Within-subjects contrasts indicated a
significant difference between Baseline and Week 3 reflecting a significant decrease in
participants level of restlessness between these two time phases, F (1, 25) = 10.05, p < .01, η2 =
.29. Although there was no significant Time x Group interaction found, F (4.03, 50.36) = 1.78, p
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= .15, η2 = .13, results of the analysis showed a non-significant “trend” toward an interaction
when comparing Experimental, Placebo, and Control group levels of restlessness at Week 3
compared to Baseline, F (2, 25) = 2.85, p = .08, η2 = .19. Looking at the interaction graph,
Figure 12, this suggests that decreases in restlessness from Baseline to Week 3 found for the
Experimental group were greater than for either the Placebo or Control group. The 4x3 mixed
design ANOVA results produced no main effect for group, indicating that there were no
significant differences in levels of restlessness between groups, F (2, 25) = 1.03, p = .37, η2 =
.08. Descriptive data showed that while both group means and overall means for restlessness
decreased by Week 3, group means for the Experimental group suggest that this decrease was
slightly more than seen for either of the other two groups.
Isolation. Table 4 contains the group means and standard deviations for the
psychological response to sport injury subscale of isolation at Baseline, Week 1, Week 2, and
Week 3, as measured by the PRSII-19. Analyses of the subscales of the PRSII produced a
significant time main effect for isolation, F (2.76, 69.07) = 3.75, p < .05, η2 = .13. Withinsubjects contrasts revealed a significant difference between Baseline and Week 3 reflecting a
significant decrease in participants level of isolation between these two time phases, F (1, 25) =
8.05, p < .01, η2 = .24. Results of the analysis also produced a significant Time x Group
interaction, F (5.53, 69.07) = 2.69, p < .05, η2 = .18. This indicates that levels of isolation at the
different time phases differed between groups. To break down this interaction, contrasts were
performed comparing each of the weekly assessments to Baseline across groups. These revealed
a significant interaction when comparing Experimental, Placebo, and Control group levels of
isolation at Week 3 compared to Baseline, F (2, 25) = 5.13, p < .05, η2 = .29. Looking at the
interaction graph, Figure 13, this suggests that decreases in isolation from Baseline to Week 3
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found for the Experimental group were significantly greater than for either the Placebo or
Control group. The 4x3 mixed design ANOVA results showed no main effect for group,
indicating that there were no significant differences in levels of isolation between groups, F (2,
25) = 1.31, p = .29, η2 = .10. Although there were significant decreases in isolation by Week 3,
it can be concluded that this decrease was significantly more pronounced for those in the
Experimental group compared to those in either the Placebo or Control groups.
3.7 Perceived Anxiety
The group means and standard deviations for perceived anxiety at Baseline, Week 1,
Week 2, and Week 3 are shown in Table 5. Results of the analysis revealed that there was no
significant main effect of time on perceived anxiety, indicating that based on overall means,
participants perceived anxiety remained relatively the same across time from Baseline to Week
3, F (2.10, 52.43) = 2.43, p = .10, η2 = .09. There was also no significant Time x Group
interaction found, F (4.20, 52.43) = 2.33, p = .07, η2 = .16, however, within-subjects contrasts
indicated a non-significant “trend” toward an interaction when comparing Experimental,
Placebo, and Control group levels of anxiety at Week 1 compared to Baseline, F (2, 25) = 3.29, p
= .05, η2 = .21. Looking at the interaction graph, Figure 14, this suggests that improvements in
perceived anxiety from Baseline to Week 1 found for the Experimental group were greater than
for either the Placebo or Control group. The 4x3 mixed design ANOVA results showed no main
effect for group, indicating that there were no significant differences in perceived anxiety
between groups, F (2, 25) = 1.09, p = .35, η2 = .08. Descriptive data showed that group means
for the Experimental group showed a decrease over time, whereas both the Placebo and Control
groups either increased over time or remained approximately the same.
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3.8 Pain Catastrophizing
Total. Table 6 contains the group means and standard deviations for pain catastrophizing
at Baseline, Week 1, Week 2, and Week 3. Results of the analysis produced a significant main
effect of time on pain catastrophizing, F (3, 75) = 8.33, p < .001, η2 = .25. Within-subjects
contrasts revealed significant differences between Baseline and Week 1, F (1, 25) = 12.34, p <
.01, η2 = .33, Baseline and Week 2, F (1, 25) = 15.20, p < .01, η2 = .38, and Baseline and Week
3, F (1, 25) = 15.82, p < .01, η2 = .39, indicating that based on overall means, participants level
of pain catastrophizing significantly decreased across the time phases. There was no significant
Time x Group interaction found, F (6, 75) = 1.77, p = .12, η2 = .12. Although not significant,
group means suggest that the decrease in pain catastrophizing across time was greater for the
Experimental group than the Placebo or Control groups (see Table 6). The 4x3 mixed design
ANOVA results showed no main effect for group, indicating that there were no significant
differences in pain catastrophizing between groups, F (2, 25) = .44, p = .65, η2 = .03. For the
Time x Group interaction graph, see Figure 15.
Rumination. The group means and standard deviations for the pain catastrophizing
subscale of rumination at Baseline, Week 1, Week 2, and Week 3 are shown in Table 6.
Analyses of the subscales of the PCS showed a significant time main effect for rumination, F
(3,75) = 5.48, p < .01, η2 = .18. Within-subjects contrasts revealed significant differences
between Baseline and Week 2, F (1, 25) = 11.22, p < .01, η2 = .31, and Baseline and Week 3, F
(1, 25) = 9.38, p < .01, η2 = .27, indicating that based on overall means, participants level of
rumination significantly decreased across the time phases. There was no significant Time x
Group interaction found, F (6, 75) = 1.80, p = .11, η2 = .13. Although not significant, group
means suggest that the decrease in rumination from Baseline to Week 3 was greater for the
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Experimental group than the Placebo or Control groups (see Table 6). The 4x3 mixed design
ANOVA results produced no main effect for group, indicating that there were no significant
differences in rumination between groups, F (2, 25) = .45, p = .65, η2 = .03. For the Time x
Group interaction graph for rumination, see Figure 16.
Magnification. The group means and standard deviations for the pain catastrophizing
subscale of magnification at Baseline, Week 1, Week 2, and Week 3 are shown in Table 6.
Analyses of the subscales of the PCS produced a non-significant “trend” towards a time main
effect for magnification, F (3,75) = 2.36, p = .08, η2 = .09. With the time main effect
approaching significance, the within-subjects contrasts showed significant differences between
Baseline and Week 2, F (1, 25) = 4.77, p < .05, η2 = .16, and Baseline and Week 3, F (1, 25) =
7.13, p < .05, η2 = .22, indicating that based on overall means, participants level of magnification
decreased across the time phases, from Baseline to Week 2 and from Baseline to Week 3. There
was also a non-significant “trend” towards a Time x Group interaction found, F (6, 75) = 1.79, p
= .11, η2 = .13, with within-subjects contrasts revealing a significant interaction when comparing
Experimental, Placebo, and Control group levels of magnification at Week 3 compared to
Baseline, F (2, 25) = 4.98, p < .05, η2 = .29. To further explore these findings, the analysis for
magnification was performed again using a 2x3 mixed design ANOVA, which confirmed the
findings that based on overall means; magnification was significantly lower at Week 3 than at
Baseline, however improvements in magnification between these two time phases were
significantly greater for the Experimental group than either the Placebo or Control group (see
Figure 17). The 4x3 mixed design ANOVA results showed no main effect for group, indicating
that there were no significant differences in magnification between groups, F (2, 25) = .66, p =
.52, η2 = .05.
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Helplessness. The group means and standard deviations for the pain catastrophizing
subscale of helplessness at Baseline, Week 1, Week 2, and Week 3 are shown in Table 6.
Analyses of the subscales of the PCS revealed a significant time main effect for helplessness, F
(3,75) = 10.66, p < .001, η2 = .30. Within-subjects contrasts showed significant differences
between Baseline and Week 1, F (1, 25) = 22.08, p < .001, η2 = .47, Baseline and Week 2, F (1,
25) = 16.44, p < .001, η2 = .40, and Baseline and Week 3, F (1, 25) = 18.03, p < .001, η2 = .42,
indicating that based on overall means, participants level of helplessness significantly decreased
across the time phases (see Figure 18). There was no significant Time x Group interaction
found, F (6, 75) = 1.02, p = .42, η2 = .08. The 4x3 mixed design ANOVA results showed no
main effect for group, indicating that there were no significant differences in helplessness
between groups, F (2, 25) = .25, p = .78, η2 = .02.
3.9 Perceived Pain
Table 7 contains the group means and standard deviations for perceived pain at Baseline,
Week 1, Week 2, and Week 3, as measured by the VAS. Results of the analysis showed a
significant main effect for time on perceived pain, F (3, 72) = 2.88, p < .05, η2 = .11. Withinsubjects contrasts revealed a significant difference between Baseline and Week 3 reflecting a
significant decrease in participants level of perceived pain between these two time phases, F (1,
24) = 9.96, p < .01, η2 = .29. There was no significant Time x Group interaction found, F (6, 72)
= 1.12, p = .36, η2 = .09. The 4x3 mixed design ANOVA results showed no main effect for
group, indicating that there were no significant differences in perceived pain between groups, F
(2, 24) = .04, p = .96, η2 = .003. As Figure 19 shows, group means for perceived pain were
relatively low among participants at Baseline and were found to be significantly improved at
Week 3.
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3.10 Pain Disability
The group means and standard deviations for pain disability at Baseline, Week 1, Week
2, and Week 3 are shown in Table 8. Results of the analysis produced a significant main effect
for time on pain disability, F (2.63, 65.70) = 16.24, p < .001, η2 = .39. Within-subjects contrasts
showed significant differences between Baseline and Week 1, F (1, 25) = 4.61, p < .05, η2 = .16,
Baseline and Week 2, F (1, 25) = 11.75, p < .01, η2 = .32, and Baseline and Week 3, F (1, 25) =
42.77, p < .001, η2 = .63, indicating that based on overall means, participants pain disability
significantly decreased across the time phases. There was no significant Time x Group
interaction found, F (5.26, 65.70) = 1.28, p = .28, η2 = .09. The 4x3 mixed design ANOVA
results revealed no main effect for group, indicating that there were no significant differences in
pain disability between groups, F (2, 25) = .73, p = .49, η2 = .06. As Figure 20 shows, group
means for perceived pain disability levels were relatively low at Baseline and further decreased
across time.
3.11 Rehabilitation Adherence
Rehabilitation adherence was assessed at one point only (i.e., Week 3), so a one-way
ANOVA was performed to examine for between-group differences.
Frequency. For the rehabilitation adherence subscale of frequency, results of the
analysis found no significant group differences in the frequency with which participants engaged
in their rehabilitation exercises, F (2, 23) = .004, p = N.S. (see Figure 21).
Duration. For the rehabilitation adherence subscale of duration, results of the analysis
found no significant group differences in duration spent performing rehabilitation exercises, F (2,
25) = .01, p = N.S. (see Figure 22).
Quality. For the rehabilitation adherence subscale of quality, results of the analysis found
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no significant group differences in participants subjective ratings of the quality with which
rehabilitation exercises were performed, F (2, 25) = 1.73, p = .20 (see Figure 23).
3.12 Physiological Measures
Mean HR – rest. Table 9 contains the group means and standard deviations for mean HR
during Task A – Rest Period at Baseline, Week 1, Week 2, and Week 3. Results of the analysis
showed that there was a non-significant “trend” towards a time main effect for mean HR – rest,
indicating that although not significant, based on overall means, mean HR during Task A – rest
period slightly increased across time from Baseline to Week 3, F (3, 72) = 2.64, p = .06, η2 = .10.
There was, however no significant Time x Group interaction found, reflecting that changes in
HR – rest at the different time phases did not significantly differ between groups, F (6, 72) =
1.90, p = .09, η2 = .14 (see Figure 24). The 4x3 mixed design ANOVA results also showed no
main effect for group, indicating that there were no significant differences in HR – rest between
groups, F (2, 24) = .88, p = .43, η2 = .07.
Mean HR – paced. Table 9 contains the group means and standard deviations for mean
HR during Task B – Paced Breathing Exercise at Baseline, Week 1, Week 2, and Week 3.
Results of the analysis of mean HR – paced showed no significant main effect for time,
indicating that, based on overall means, participants mean HR during Task B – paced breathing
exercise remained relatively the same across time from Baseline to Week 3, F (3, 66) = 1.68, p =
.18, η2 = .07. There was also no significant Time x Group interaction found, F (6, 66) = 1.89, p
= .10, η2 = .15. The 4x3 mixed design ANOVA results produced no main effect for group,
indicating that there were also no significant differences in mean HR – paced between groups, F
(2, 22) = .77, p = .48, η2 = .07 (see Figure 25).
SDNN – rest. The group means and standard deviations for the HRV time-domain
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indices of SDNN during Task A – Rest Period at Baseline, Week 1, Week 2, and Week 3 are
shown in Table 10. Results of the analysis revealed a significant time main effect for SDNN –
rest, F (3, 72) = 3.90, p < .05, η2 = .14. Within-subjects contrasts indicated significant
differences between Baseline and Week 1, F (1, 24) = 10.92, p < .01, η2 = .31, and Baseline and
Week 2, F (1, 24) = 5.51, p < .05, η2 = .19, reflecting a significant increase in SDNN – rest
between Baseline and these two time phases. Results of the analysis also produced a nonsignificant “trend” towards a Time x Group interaction, F (6, 72) = 1.98, p = .08, η2 = .14, with
within-subjects contrasts revealing a significant interaction when comparing Experimental,
Placebo, and Control group measures of SDNN – rest at Week 1 compared to Baseline, F (2, 24)
= 3.90, p < .05, η2 = .25, and a borderline significant interaction at Week 2 compared to
Baseline, F (2, 24) = 3.39, p = .05, η2 = .22. This suggests that the increases in SDNN – rest
from Baseline to Week 1 and from Baseline to Week 2 for the Experimental group were greater
than for either the Placebo or Control group (see Figure 26). The 4x3 mixed design ANOVA
results showed no main effect for group, indicating that there were no significant differences in
SDNN – rest between groups, F (2, 24) = .66, p = .53, η2 = .05.
SDNN – paced. The group means and standard deviations for the HRV time-domain
indices of SDNN during Task B – Paced Breathing Exercise at Baseline, Week 1, Week 2, and
Week 3 are shown in Table 10. Results of the analysis produced a significant time main effect
for SDNN – paced, F (3, 66) = 4.70, p < .01, η2 = .18. Within-subjects contrasts revealed a
significant difference between Baseline and Week 1, indicating that based on overall means,
SDNN – paced significantly increased between these two time phases, F (1, 22) = 5.15, p < .05,
η2 = .19. There was no significant Time x Group interaction found, F (6, 66) = 1.29, p = .27, η2
= .11 (see Figure 27). The 4x3 mixed design ANOVA results showed no main effect for group,
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indicating that there were no significant differences in SDNN – paced between groups, F (2, 22)
= 1.09, p = .36, η2 = .09.
Total HRV – rest. Table 11 contains the group means and standard deviations for the
HRV frequency-domain indices of total HRV during Task A – Rest Period at Baseline, Week 1,
Week 2, and Week 3. Results of the analysis showed a significant main effect for time on total
HRV – rest, F (3, 72) = 3.62, p < .05, η2 = .13. Within-subjects contrasts revealed a significant
difference between Baseline and Week 1, indicating based on overall means, a significant
increase in total HRV – rest between these two time phases, F (1, 24) = 9.35, p < .01, η2 = .28.
There was no significant Time x Group interaction found, reflecting that changes in total HRV –
rest at the different time phases did not significantly differ between groups, F (6, 72) = 1.51, p =
.19, η2 = .11 (see Figure 28). The 4x3 mixed design ANOVA results produced no main effect
for group, indicating that there were no significant differences in total HRV – rest between
groups, F (2, 24) = 1.04, p = .37, η2 = .08.
Total HRV – paced. Table 11 contains the group means and standard deviations for the
HRV frequency-domain indices of total HRV during Task B – Paced Breathing Exercise at
Baseline, Week 1, Week 2, and Week 3. Results of the analysis produced a significant time
main effect for total HRV – paced, F (3, 66) = 3.82, p < .05, η2 = .15. Within-subjects contrasts
showed a non-significant “trend” for differences between Baseline and Week 1, indicating that
based on overall means, total HRV – paced increased between these two time phases, F (1, 22) =
3.55, p = .07, η2 = .14. Upon further analysis with a within-subjects repeated contrast, it was
found that there was a significant difference between Week 2 and Week 3, reflecting a
significant decrease in total HRV – paced between these two time phases, F (1, 22) = 6.02, p <
.05, η2 = .22. There was no significant Time x Group interaction found, indicating that changes
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in total HRV – paced at the different time phases did not significantly differ between groups, F
(6, 66) = .70, p = .65, η2 = .06 (see Figure 29). The 4x3 mixed design ANOVA results produced
no main effect for group, indicating that there were no significant differences in total HRV –
paced between groups, F (2, 22) = 1.50, p = .25, η2 = .12.
LF HRV – rest. The group means and standard deviations for the HRV frequencydomain indices of LF HRV during Task A – Rest Period at Baseline, Week 1, Week 2, and Week
3 are shown in Table 12. Results of the analysis showed a significant time main effect for LF
HRV – rest, F (3, 72) = 5.04, p < .01, η2 = .17. Within-subjects contrasts revealed significant
differences between Baseline and Week 1, F (1, 24) = 16.16, p < .01, η2 = .40, Baseline and
Week 2, F (1, 24) = 6.56, p < .05, η2 = .22, and Baseline and Week 3, F (1, 24) = 5.54, p < .05,
η2 = .19, indicating based on overall means, a significant increase in LF HRV – rest across the
time phases. Results of the analysis also produced a significant Time x Group interaction, F (6,
72) = 2.72, p < .05, η2 = .19. This indicates that LF HRV – rest at the different time phases
differed between groups. To break down this interaction, contrasts were performed comparing
each of the weekly assessments to Baseline across groups. These revealed significant
interactions when comparing Experimental, Placebo, and Control group measures of LF HRV –
rest at Week 1 compared to Baseline, F (2, 24) = 7.26, p < .01, η2 = .38, and Week 2 compared to
Baseline, F (2, 24) = 6.65, p < .01, η2 = .36. Looking at the interaction graph, Figure 30, this
suggests that increases in LF HRV – rest from Baseline to Week 1 and from Baseline to Week 2
for the Experimental group were significantly greater than for either the Placebo or Control
group. The 4x3 mixed design ANOVA results produced no main effect for group, indicating that
there were no significant differences in LF HRV – rest between groups, F (2, 24) = 1.94, p = .17,
η2 = .14. Although based on overall means, LF HRV – rest increased across time from Baseline,
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it can be concluded that this increase was significantly more pronounced for those in the
Experimental group compared to those in either the Placebo or Control groups.
LF HRV – paced. The group means and standard deviations for the HRV frequencydomain indices of LF HRV during Task B – Paced Breathing Exercise at Baseline, Week 1,
Week 2, and Week 3 are shown in Table 12. Results of the analysis produced a significant time
main effect for LF HRV – paced, F (3, 66) = 3.67, p < .05, η2 = .14. Within-subjects contrasts
showed a non-significant “trend” for differences between Baseline and Week 1, indicating that
based on overall means, LF HRV – paced increased between these two time phases, F (1, 22) =
3.95, p = .06, η2 = .15. Upon further analysis with a within-subjects repeated contrast, it was
found that there was a significant difference between Week 2 and Week 3, reflecting a
significant decrease in LF HRV – paced between these two time phases, F (1, 22) = 4.42, p <
.05, η2 = .17. There was no significant Time x Group interaction found, indicating that changes
in LF HRV – paced at the different time phases did not significantly differ between groups, F (6,
66) = 1.48, p = .20, η2 = .12 (see Figure 31). The 4x3 mixed design ANOVA results revealed no
main effect for group, indicating that there were no significant differences in LF HRV – paced
between groups, F (2, 22) = 1.36, p = .28, η2 = .11.
HF HRV – rest. Table 13 contains the group means and standard deviations for the HRV
frequency-domain indices of HF HRV during Task A – Rest Period at Baseline, Week 1, Week
2, and Week 3. Results of the analysis revealed that there was no significant main effect of time
on HF HRV – rest, indicating that based on overall assessment means, measures of HF HRV –
rest remained relatively the same across time from Baseline to Week 3, F (2.44, 58.66) = 1.29, p
= .29, η2 = .05. There was also no significant Time x Group interaction found, F (4.89, 58.66) =
.99, p = .43, η2 = .08 (see Figure 32). The 4x3 mixed design ANOVA results showed no main
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effect for group, indicating that there were no significant differences in HF HRV – rest between
groups, F (2, 24) = 1.80, p = .19, η2 = .13.
HF HRV – paced. Table 13 contains the group means and standard deviations for the
HRV frequency-domain indices of HF HRV during Task B – Paced Breathing Exercise at
Baseline, Week 1, Week 2, and Week 3. Results of the analysis produced a significant time
main effect for HF HRV – paced, F (3, 66) = 4.65, p < .01, η2 = .18. Within-subjects contrasts
showed a significant difference between Baseline and Week 1, indicating that based on overall
means, HF HRV – paced significantly increased between these two time phases, F (1, 22) = 5.06,
p < .05, η2 = .19. Upon further analysis with a within-subjects repeated contrast, it was found
that there was also a significant difference between Week 2 and Week 3, reflecting a significant
decrease in HF HRV – paced between these two time phases, F (1, 22) = 4.81, p < .05, η2 = .18.
This indicates that although HF HRV – paced significantly increased by Week 1, measures of HF
HRV – paced decreased thereafter. There was no significant Time x Group interaction found,
indicating that changes in HF HRV – paced at the different time phases did not significantly
differ between groups, F (6, 66) = .27, p = .95, η2 = .02 (see Figure 33). The 4x3 mixed design
ANOVA results produced no main effect for group, indicating that there were no significant
differences in HF HRV – paced between groups, F (2, 22) = 1.61, p = .22, η2 = .13.
Mean Respiration Rate – rest. The group means and standard deviations for mean
respiration rate during Task A – Rest Period at Baseline, Week 1, Week 2, and Week 3 are
shown in Table 14. Results of the analysis produced a significant time main effect for mean
respiration rate – rest, F (3, 72) = 14.96, p < .001, η2 = .38. Within-subjects contrasts revealed
significant differences between Baseline and Week 1, F (1, 24) = 24.38, p < .001, η2 = .50,
Baseline and Week 2, F (1, 24) = 25.92, p < .001, η2 = .52, and Baseline and Week 3, F (1, 24) =
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28.54, p < .001, η2 = .54, reflecting a significant decrease in participants mean respiration rates
during Task A – rest period across the time phases. Results of the analysis also produced a
significant Time x Group interaction, F (6, 72) = 7.37, p < .001, η2 = .38. This indicates that
rates of breathing at the different time phases differed between groups. To break down this
interaction, contrasts were performed comparing each of the weekly assessments to Baseline
across groups. These revealed significant interactions when comparing Experimental, Placebo,
and Control group respiration rate – rest measures at Week 1 compared to Baseline, F (2, 24) =
8.96, p < .01, η2 = .43, Week 2 compared to Baseline, F (2, 24) = 15.33, p < .001, η2 = .56, and
Week 3 compared to Baseline, F (2, 24) = 13.22, p < .001, η2 = .52. Looking at the interaction
graph, Figure 34, this suggests that decreases in mean respiration rate during Task A – rest
period from Baseline to Week 1, Week 2, and Week 3 found for the Experimental group were
significantly greater than for either the Placebo or Control group. The 4x3 mixed design
ANOVA results also showed a significant main effect for group, indicating that there were
significant differences in respiration rates during Task A between groups, F (2, 24) = 6.32, p <
.01, η2 = .35. Tukey follow-up tests revealed that respiration rates during Task A across
assessments for the HRV BFB Experimental group were significantly lower than those for either
the Placebo or Control group. However, there were no significant differences in respiration rates
– rest between the Placebo and Control groups.
Mean Respiration Rate – paced. The group means and standard deviations for mean
respiration rate during Task B – Paced Breathing Exercise at Baseline, Week 1, Week 2, and
Week 3 are shown in Table 14. Results of the analysis showed that there was no time main
effect for mean respiration rate – paced, indicating that based on overall means, mean respiration
rates during Task B – paced breathing exercise remained relatively the same across time from
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Baseline to Week 3, F (2.62, 60.16) = 2.78, p = .06, η2 = .11. There was also no significant Time
x Group interaction found, reflecting that changes in respiration rate – paced at the different time
phases did not significantly differ between groups, F (5.23, 60.16) = .57, p = .73, η2 = .05 (see
Figure 35). The 4x3 mixed design ANOVA results also revealed no main effect for group,
indicating that there were no significant differences in respiration rates during Task B between
groups, F (2, 23) = .13, p = .88, η2 = .01.

HEART RATE VARIABILITY BIOFEEDBACK

64

Chapter 4: Discussion
The following chapter will serve to (a) present a summary of the study results and
highlight key findings, (b) compare and contrast the findings presented herein with those of
previous studies, (c) emphasize current study strengths and limitations, (d) direct attention
towards future recommendations in this field of study, and finally (e) specify both theoretical and
practical implications.
4.1 Summary of Findings
The purpose of the current study was to examine the effectiveness of HRV biofeedback, a
form of psychophysiological skills training intervention, to improve athletes’ psychological
response following an injury. Specifically, to explore the effects of HRV BFB training on
rehabilitation self-efficacy, perceived stress and anxiety, pain management, and the
psychological responses of injured athletes. The effectiveness of the HRV BFB intervention to
facilitate improvements in athletes’ physiological indices including HRV, HR, and respiration
rate was also assessed. A 4 x 3 mixed model design (Time: Baseline, Week 1, Week 2, Week 3;
assessments across time; Group: HRV BFB Experimental group, HRV BFB Placebo group,
Control group; experimental conditions) was used to examine the emotional experience and
psychological responses of injured athletes as they progressed through injury recovery over a
three-week duration. Different experimental conditions were employed in order to evaluate the
effectiveness of HRV BFB in (a) improving athletes' psychological responses regarding injury
and rehabilitation, (b) promoting increased perceptions of self-efficacy and reorganization, (c)
contributing to reductions in perceived stress, anxiety, pain, and pain catastrophizing, (d)
fostering declines in disability due to pain, and (e) demonstrating improvements in physiological
indices. It was hypothesized that injured athletes who received the HRV BFB intervention
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would demonstrate significantly greater improvements in psychological outcomes pertaining to
injury and rehabilitation across time than injured athletes who were not provided with this form
of intervention (i.e., HRV BFB Placebo group and Control group). As a secondary hypothesis, it
was hypothesized that injured athletes who received the HRV BFB intervention would also
demonstrate significantly greater improvements in physiological indices corresponding to BFB
training than injured athletes who were not provided with this form of intervention (i.e., HRV
BFB Placebo group and Control group).
Psychological outcomes. Results provided partial support in terms of the first hypothesis
regarding the influence of the HRV BFB intervention on athletes’ psychological outcomes
pertaining to injury and rehabilitation. Injured athletes who received the HRV BFB intervention
reported significantly greater improvements on a number of psychological outcomes than those
in either the placebo or control groups. Results with respect to each of the specific psychological
outcomes measured will be discussed.
Perceptions of task self-efficacy regarding rehabilitation were found to be high among
injured athletes in each group at Baseline. Results suggest that injured athletes, regardless of the
group to which they were assigned, maintained high task self-efficacy regarding rehabilitation
across time. Although differences in task self-efficacy between groups did not reach statistical
significance, observation of group means showed the HRV BFB Experimental and HRV BFB
Placebo groups to have higher levels of task-self efficacy than the Control group regarding injury
rehabilitation. Perceptions of coping self-efficacy regarding rehabilitation were also relatively
high among injured athletes in each group at Baseline, however, there was also a significant
main effect for time on coping self-efficacy in that injured athletes across groups were
significantly higher in coping self-efficacy at Week 3 compared to Baseline. Similar to the
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results found for task self-efficacy, although not statistically significant, observation of group
means showed the HRV BFB Experimental and HRV BFB Placebo groups to have higher levels
of coping self-efficacy than the Control group regarding injury rehabilitation. High perceptions
of task and coping self-efficacy over the three-week duration among the injured athletes in the
current study is in line with previous research which examined injured athletes perceptions of
self-efficacy during an eight week rehabilitation program and found that mean scores for both
task and coping self-efficacy remained relatively stable and high (Wesch et al., 2012). The high
self-efficacy scores reported by injured athletes in the current study may also be associated with
the fact that 79% of participants had a previous history of athletic injury. Bassett and
Prapavessis (2010) proposed that high self-efficacy among injured athletes may be attributed to
participants having had prior experience with athletic injury and rehabilitation programs. The
findings of the present study are also consistent with those reported by Evans and Hardy (2002)
in a goal setting study with injured athletes, who found that a goal setting intervention group and
social support control group both had higher levels of self-efficacy than the no treatment control
group. In terms of perceived stress, results demonstrated a significant main effect of time
between Baseline and Week 3 indicating that injured athletes across groups experienced
significant reductions in perceived stress between these two time phases.
Results of the current investigation supported the hypothesis that HRV BFB would
significantly improve athletes’ psychological responses post-injury, as measured by the PRSII-19
(Evans et al., 2008). Injured athletes’ negative psychological responses regarding injury and
recovery (with the exception of feeling cheated) were found to significantly decrease across time.
Specifically, with regards to devastation, the results indicated that while based on overall means,
there were significant reductions in injured athletes’ levels of devastation each week as
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compared to Baseline; the HRV BFB Experimental group demonstrated significantly greater
reductions in devastation than either of the other two groups across time. Not only did the HRV
BFB Experimental group report significantly greater improvements in levels of devastation at
each assessment, but group means show these individuals were the highest in devastation at
Baseline and reported the lowest levels of devastation by Week 3. This speaks to the potential
effectiveness of HRV BFB to reduce feelings of devastation in injured athletes post-injury and
throughout the rehabilitation process. Individuals in the HRV BFB Experimental group reported
significantly greater reductions in terms of feelings of intense shock and devastation across time
(Evans et al., 2008), as compared to injured athletes who received a sham HRV BFB intervention
and those who received no training throughout their recovery. In terms of the psychological
response to sport injury subscale of reorganization, which represents feelings of increased
confidence and a sense of psychological recovery (Evans et al., 2008), results of the current
study revealed that, based on overall means, perceptions of reorganization among injured athletes
significantly increased across time from Baseline to Week 2 and Baseline to Week 3. However,
injured athletes in the HRV BFB Experimental group reported significantly greater increases in
feelings of reorganization than those in either the Placebo or Control groups across time. Similar
to the findings regarding devastation, this speaks to the potential of HRV BFB as a useful tool
for fostering increased feelings of reorganization in injured athletes recovering from athletic
injury. Individuals in the HRV BFB Experimental group demonstrated significantly greater
improvements in terms of feelings of confidence and perceptions of psychological recovery, as
compared to injured athletes who received a HRV BFB Placebo condition and those who
received no training throughout their recovery.
Looking at the psychological response to sport injury subscale of feeling cheated, based

HEART RATE VARIABILITY BIOFEEDBACK

68

on overall means, it was found that injured athletes remained relatively stable in feeling cheated
regarding their injury across time. Results of the current study did not reveal any significant
differences between groups in terms of their reductions of feeling cheated over time, however, an
exploratory analysis showed that while group means for both the Placebo and Control groups
remained the same or increased over time, group means for the HRV BFB Experimental group
showed reductions in the psychological response to sport injury of feeling cheated, which can be
defined as representing feelings of bitterness towards being injured (Evans et al., 2008). This
trend should be investigated further in future studies examining the effects of HRV BFB in the
athletic injury population. With regards to the subscale of restlessness, which has been
characterized by feelings of anxiety, guilt, and hostility (Evans et al., 2008), results indicated,
based on overall means, that injured athletes demonstrated significant reductions in feelings of
restlessness by Week 3. While it was not statistically significant, there were trends indicating
that the HRV BFB Experimental group displayed greater reductions in restlessness compared to
either of the other groups across time. Similar to devastation, group means show that these
individuals were the highest in feelings of restlessness at Baseline and reported the lowest levels
of restlessness by Week 3. It follows that HRV BFB may be effective in promoting reductions in
feelings of restlessness in injured athletes post-injury and throughout the rehabilitation process.
Individuals in the HRV BFB Experimental group reported greater declines in terms of feelings of
anxiety, hostility, and guilt by Week 3 post-intervention, as compared to injured athletes who
received a HRV BFB Placebo condition and those who received no training throughout their
recovery.
Finally, in terms of feelings of isolation, results of the study demonstrated, based on
overall means, that there were significant reductions in injured athletes’ levels of perceived
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isolation by Week 3, post-intervention. With this being said, the HRV BFB Experimental group
reported significantly greater reductions in feelings of isolation than either of the other two
groups between Baseline and Week 3. Not only did the HRV BFB Experimental group report
significantly greater improvements in isolation at Week 3, but group means show that these
individuals were the highest in feelings of isolation at Baseline and reported the lowest levels of
isolation by Week 3. This speaks to the potential effectiveness of HRV BFB to contribute to
reductions in feelings of isolation in injured athletes post-injury and throughout the rehabilitation
process. The findings surrounding the effects of HRV BFB training on athletes’ psychological
responses following injury are consistent with previous research regarding the use of goal setting
as a form of psychological skills training for injured athletes (Evans & Hardy, 2002). Although,
whereas Evans & Hardy (2002) only found differences across time on measures of psychological
responses to sport injury, the current study demonstrated significantly greater improvements on a
number of these variables in the HRV BFB Experimental group, compared to the Placebo and
Control groups. The current findings are also consistent with previous research findings
regarding the use of HRV BFB in other populations and its beneficial effects on stress, anxiety,
negative affect, and mood disturbances (Hassett et al., 2007; Karavidas et al., 2007; Lagos et al.,
2008; Paul & Garg, 2012).
With regards to perceived anxiety, study findings indicated that, based on overall means,
injured athletes remained relatively stable in perceived anxiety across time. Results of the
current study did not reveal any significant differences between groups in terms of their
reductions in perceived anxiety, however, an exploratory analysis showed that while group
means for both the Placebo and Control groups remained the same or increased over time, group
means for the HRV BFB Experimental group showed declines in perceived anxiety. Further,
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group means show that these individuals were the highest in perceptions of anxiety at Baseline
and reported the lowest levels of anxiety by Week 3. From this, it is speculated that HRV BFB
may be effective in fostering declines in levels of anxiety in injured athletes post-injury and
throughout the rehabilitation process. This trend should be investigated further in future studies
examining the effects of HRV BFB in the athletic injury population. The findings of the present
study are somewhat consistent with previous research regarding the use of HRV BFB in other
populations and its beneficial effects on anxiety levels (Siepmann et al., 2008; Lagos et al., 2008;
Paul & Garg, 2012). The trends in lowered anxiety levels demonstrated by injured athletes in
this study are consistent with findings found by Paul and Garg (2012), which showed that a
group of basketball players demonstrated significantly less anxiety after undergoing a HRV BFB
intervention. Findings of the current study regarding anxiety also show similarities between the
effects of HRV BFB and other psychological interventions that have been employed with injured
athletes. Ross and Berger (1996) found that a stress inoculation-training program significantly
reduced anxiety in the intervention group in the post-surgical rehabilitation process, as compared
to controls.
Findings of the current investigation revealed that, based on overall means, injured
athletes showed significant reductions in levels of pain catastrophizing across time from Baseline
to each subsequent week, respectively. Results did not reveal any significant differences
between groups in terms of their reductions in pain catastrophizing over time, however, group
means suggest that injured athletes in the HRV BFB Experimental group demonstrated a greater
decline in pain catastrophizing over time from Baseline to Week 3, compared to either of the
other two groups. In terms of the pain catastrophizing subscale of rumination, findings indicated
again that, based on overall means, injured athletes’ levels of pain rumination significantly
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declined across time. As seen with pain catastrophizing, group means suggest that injured
athletes in the HRV BFB Experimental group showed a greater decline in rumination regarding
pain from Baseline to Week 3, post-intervention, than either of the other two groups. However,
this did not reach statistical significance. With regards to the pain catastrophizing subscale of
magnification, results of the study demonstrated that, based on overall means, there were
significant reductions in injured athletes’ levels of pain magnification by Week 3, postintervention. With this being said, the HRV BFB Experimental group reported significantly
greater reductions in magnification regarding pain than either of the other two groups between
Baseline and Week 3. This speaks to the potential effectiveness of HRV BFB to contribute to
declines in pain magnification in injured athletes post-injury and throughout the rehabilitation
process. Finally, findings regarding the subscale of helplessness showed that, based on overall
means, injured athletes reported significant reductions in levels of helplessness across time from
Baseline to each subsequent week, respectively. Results did not reveal any significant
differences between groups in terms of their reductions in helplessness regarding pain, however,
an exploratory analysis showed that individuals in the HRV BFB Experimental group were the
highest in feelings of helplessness at Baseline and reported the lowest levels of helplessness by
Week 3. The findings of the current study are in line with those of previous research by Riddle
et al. (2011), who investigated the effects of a pain coping skills intervention in patients
scheduled for knee arthroplasty procedures and found that those who received the coping skills
training demonstrated significantly greater reductions in pain catastrophizing, compared to a
usual care cohort. The findings of the current study suggest that HRV BFB may be effective in
promoting declines in levels of pain catastrophizing in injured athletes following injury and
throughout the subsequent recovery process.
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In terms of perceived pain experienced by injured athletes post-injury, findings
demonstrated, based on overall means, that there were significant reductions in athletes’ levels of
perceived pain by Week 3, post-intervention. However, results of the current study did not
reveal any significant differences between groups in terms of their reductions in perceived pain
over time. These findings are consistent with those of previous injury rehabilitation research by
Brewer et al. (2007) who found that daily pain ratings decreased significantly over the first six
weeks of rehabilitation following ACL reconstruction. However, prior research involving the
use of psychological skills interventions in injury rehabilitation has found that individuals who
received stress inoculation training demonstrated significantly less post-surgical pain during the
rehabilitation process, compared with controls (Ross & Berger, 1996). Future research will need
to focus inquiries into the effects of BFB on injured athletes’ levels of perceived pain.
With regards to pain disability, results of the current study revealed that, based on overall
means, perceptions of disability due to pain among injured athletes significantly decreased across
time from Baseline to each week, respectively. Results did not reveal any significant differences
between groups in terms of their reductions in pain disability; however, an exploratory analysis
suggested that declines in perceived disability due to pain were greater for those in the HRV
BFB Experimental group, compared to those for either of the other two groups. These findings
are consistent with those of previous research employing a HRV BFB intervention in a chronic
low-back pain population (Kapitza et al., 2010) which found no significant differences in terms
of pain disability reductions between a BFB intervention and placebo group, but commented that
pre-post changes in the intervention group were higher than in the placebo group. It is possible
that receiving the HRV BFB intervention fostered greater declines in perceived disability due to
pain throughout rehabilitation, as compared to not receiving the HRV BFB intervention.
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Adherence, measured in terms of frequency, duration, and quality, was found to be high
among injured athletes in each of the three groups. This is not surprising given the high scores in
both task and coping self-efficacy reported by injured athletes in the current study, which has
been associated with high levels of rehabilitation adherence (Brewer et al., 2003, Wesch et al.,
2012).
Physiological outcomes. Results provided partial support in terms of the second
hypothesis made regarding the influence of the HRV BFB intervention on athletes’ physiological
indices. Injured athletes who received the HRV BFB intervention demonstrated significantly
greater declines in resting respiration rate and significantly greater increases in LF HRV at rest
than those in either the placebo or control groups. Results with respect to each of the specific
physiological indices will be discussed.
It was hypothesized that injured athletes in the HRV BFB Experimental group would
report significantly greater declines in heart rate (HR) during both Task A – Rest Period and
Task B – Paced Breathing Exercise over the three-week study duration, than those in either of
the other two groups, who were expected to remain relatively the same across time. However,
findings of the current study did not support this hypothesis. Results indicated that, based on
overall means, injured athletes’ average heart rates (during both Task A and Task B) remained
relatively stable across time. Further, there were no significant differences between groups in
terms of their variation in HR across time. Surprisingly, group means actually suggest a slight
increase in the heart rates of injured athletes between Baseline and Week 3, post-intervention.
These findings are not consistent with previous research on the use of HRV BFB with depressed
individuals (Siepmann et al., 2008), in which it was found that depressed patients had
significantly reduced heart rates under conditions of both relaxed rest and paced breathing after
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receiving six sessions of HRV BFB over a two-week duration. There are a number of reasons
for why injured athletes in the current study (especially those in the HRV BFB Experimental
group) did not show reduced heart rates over time. First, in previous studies examining the
effects of HRV BFB, the populations under review have been clinical in nature and/or involving
participants considered to be ‘unhealthy’ populations. While upon initial hypotheses, it was
speculated that injured athletes might have shown increased heart rates post-injury, similar to
what has been seen in depressed individuals, this appears to not have been the case. The
participants in the current study were young, relatively healthy (with exception of injury),
competitive athletes and it appears that HR was not influenced in a negative manner upon injury
and in dealing with the recovery process. This can explain the stability seen across time in
overall means for heart rate during both tasks. Reasons for the slight increases in heart rates
from Baseline to Week 3, seen across the groups, may have been due to participants becoming
more active as recovery progressed over time.
Findings in the current study revealed that, based on overall means, injured athletes
demonstrated significant increases in SDNN, a time-domain indices of HRV, during Task A –
Rest Period at Week 1, as compared to Baseline. SDNN, based on overall means showed a
decline thereafter, however, remained significantly increased at Week 2, and increased at Week 3
compared to Baseline. While it was not statistically significant, there were trends indicating that
the HRV BFB Experimental group displayed greater increases in SDNN during Task A,
compared to either of the other groups across time. It follows that HRV BFB training may be
effective in leading to increased HRV, as measured by SDNN, in injured athletes post-injury and
throughout the rehabilitation process. The results seen in this study are consistent with prior
HRV BFB studies by Del Pozo et al. (2004), Karavidas et al. (2007), and Zucker et al. (2009),
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who found that individuals who received a HRV BFB intervention showed significant increases
in SDNN across time. Findings of the current study regarding SDNN during Task B – Paced
Breathing Exercise were less clear. Based on overall means, SDNN during Task B significantly
increased from Baseline to Week 1, however, decreased to Baseline levels by Week 3, postintervention. There were no significant differences seen between groups in terms of variation in
SDNN during Task B across time.
With regards to the frequency-domain indices of total HRV, findings revealed that, based
on overall means, injured athletes showed significant increases in total HRV during Task A –
Rest Period at Week 1, as compared to Baseline. Total HRV, based on overall means showed a
decline thereafter, however, remained increased at Week 2 and Week 3 compared to Baseline.
Although not statistically significant, an exploratory analysis revealed that based on group
means, injured athletes in the HRV BFB Experimental group displayed greater increases in total
HRV during Task A from Baseline to Week 3, compared to those in either the Placebo or
Control groups. Findings of the current study regarding total HRV during Task B – Paced
Breathing Exercise revealed that, based on overall means, total HRV significantly increased in
injured athletes from Baseline to Week 1, however, decreased thereafter. There were no
significant differences between groups in terms of variation in total HRV during Task B across
time.
In terms of LF HRV, findings indicated that while, based on overall means, injured
athletes showed significant improvements in LF HRV during Task A – Rest Period each week as
compared to Baseline, the HRV BFB Experimental group demonstrated significantly greater
increases in LF HRV during Task A than either of the other two groups. This speaks to the
potential effectiveness of HRV BFB training to increase LF HRV in injured athletes post-injury
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and throughout the rehabilitation process. Individuals in the HRV BFB Experimental group
reported significantly greater gains in LF HRV during rest, as compared to injured athletes who
received a sham HRV BFB intervention and those who received no training throughout their
recovery. The findings regarding LF HRV during Task A in the current study are consistent with
those by Paul, Garg, and Sandhu (2012) who found that basketball players who underwent a
HRV BFB intervention demonstrated significantly greater increases in LF HRV from pre- to
post-intervention, than those in either the placebo or control groups. Findings regarding LF
HRV during Task B – Paced Breathing Exercise are consistent with those seen for Total HRV
Task B – Paced Breathing Exercise.
With regards to HF HRV, findings indicated that based on overall means, HF HRV
during Task A – Rest Period for injured athletes remained relatively stable across time from
Baseline to Week 3. Findings for HF HRV during Task B – Paced Breathing Exercise indicated
that, based on overall means, HF HRV significantly increased from Baseline to Week 1 before
decreasing to Baseline levels thereafter. For both HF HRV during Tasks A and B, results
indicated that there were no significant differences between groups in terms of variation in HF
HRV over time. A lack of change in HF HRV for those in the Placebo and Control groups was
as expected. In terms of the HRV BFB Experimental group, it was hypothesized that due to an
increase in total HRV over time, these individuals would also demonstrate increases in HF HRV.
However, Wheat and Larkin (2010) in a review of the literature on HRV BFB, concluded that all
results were in agreement that HF HRV does not increase subsequent to HRV BFB training.
This lack of change in HF HRV is proposed to be due to individuals reducing their respiratory
rate and breathing in a slow and controlled manner causing RSA to shift from the HF to the LF
range of HRV (Karavidas et al., 2007; Wheat & Larkin, 2010).
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Finally, findings revealed that while respiration rates during Task A – Rest Period
remained relatively the same for those in both the Placebo and Control groups, injured athletes in
the HRV BFB Experimental group displayed significant reductions in respiration rate during
Task A at each week, compared to Baseline. Overall, injured athletes in the HRV BFB
Experimental group had significantly lower respiration rates than injured athletes who were not
provided with HRV BFB training. These findings are consistent with those of Paul, Garg, and
Sandhu (2012) who found respiration rates to be significantly reduced in basketball players who
received HRV BFB training, compared to those who had not received such training. This speaks
to the effectiveness of HRV BFB in enhancing individuals’ awareness and control over their
respiratory patterns to aid in self-regulation and relaxation. Findings with regards to respiration
rates during Task B – Paced Breathing Exercise were as expected. All injured athletes seemed
capable of reducing respiration to approximately six breaths per minutes with the aid of a
respiratory pacer.
In conclusion, it appears that HRV BFB may hold promise as a form of psychological
skills training intervention to facilitate injured athletes throughout rehabilitation and the
subsequent recovery period. From the findings of the current investigation, it can be concluded
that a HRV BFB intervention may be an effective tool within the rehabilitation setting to
improve athletes’ psychological responses and psychological outcomes pertaining to injury and
rehabilitation.
4.2 Study Strengths
It is important to recognize the relative strengths and merit of the current study and its
respective design. First and foremost, it would appear from the literature reviewed to date that
this was the first study of its kind examining the effectiveness of a HRV BFB intervention in the
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context of an athletic injury population. While other techniques have been used within sport
psychology, the use of HRV biofeedback was a novel and new approach within the athletic
rehabilitation setting. This form of psychophysiological skills training has yet to be extensively
researched as a form of intervention to facilitate the injured athlete during their rehabilitation
process. More specifically, as a means to reduce the negative affect and emotional distress
experienced by injured athletes, while enhancing psychological traits seen to be beneficial to a
successful recovery with optimal outcomes, both physical and psychological. The current study
was therefore exploratory in nature, and the findings will inform the research community of
HRV BFB’s potential in the sport injury context. Findings from the current study may serve as a
foundation from which future studies examining the effects of HRV BFB and its relative use in
the athletic injury population may build off. Cupal (1998), in a review of the literature on
rehabilitative psychological interventions for sport injury, argued that psychological intervention
studies demonstrate preliminary evidence of treatment efficacy and that further empirical
investigation into the rehabilitative injury process is warranted. The present study not only
served to further investigate the effects of psychological skills training in the athletic injury
population, but will hopefully speak to the potential of BFB as an available and useful
rehabilitation tool, and as a plausible and efficacious technique to facilitate injured athletes
throughout recovery and in their return to sport.
The current investigation had a number of strengths in the study design. As an
intervention study exploring the effects of a novel and new approach to psychological recovery
within the athletic injury rehabilitation setting, the inclusion of both a placebo and a control
group was a relative strength. Prior research regarding the use of HRV BFB in other populations
and other forms of psychological skills training within the athletic injury setting have
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emphasized the importance of utilizing a control and/or placebo group in study designs (Hassett
et al., 2007; Cupal, 1998; Wheat & Larkin, 2010). Cupal (1998) argued that without adequate
controls, including assessing the impact of potential placebo effects in psychological
intervention, it is difficult to separate treatment effects from effects of other intervening
variables. Therefore, the current study can cite the inclusion of not only a control group, but also
a placebo or active control group as definite strength. Specific to HRV BFB interventions,
Hassett et al. (2007) expressed that these interventions should be compared to a sham or another
form of BFB to allow differentiation between actual treatment effects and potential placebo
effects or effects resulting from factors other than the intervention itself. In the current study,
this recommendation was attended to by utilization of a HRV BFB placebo group, similar to
those used in prior HRV BFB studies conducted by Lehrer et al. (2004) and Siepmann et al.
(2008). Overall, the inclusion of both a control group and placebo group in this study helped in
ruling out the Hawthorne effect and in evaluating the efficacy of the HRV BFB intervention
itself.
A further strength of the current study was the implementation of a pre-existing HRV
BFB training protocol that has been used in the majority of previous studies employing HRV
BFB interventions. The intervention utilized in the current study was structured based on the
HRV BFB training protocol outlined in the manual by Lehrer et al. (2000). This was seen as a
strength due to the fact that by incorporating a training protocol previously used in other BFB
studies with proven efficacy, procedural reliability was increased. A third strength of the current
study was the randomization of participants into the three experimental conditions. Randomly
assigning participants to one of the three experimental conditions helped in increasing the
likelihood that groups would not be vastly different in terms of demographics.
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Furthermore, inclusion of multiple data collection points or assessments was seen as a
major strength of the current study in that it allowed us to examine the temporal effects on a
number of psychological outcomes pertaining to injury and rehabilitation over the duration of a
3-week period. Including four data assessments into the study design allowed the researchers to
examine differences in perceptions of various psychological outcomes and the measured
physiological indices over time, rather than just at Baseline and post-intervention. Due to
previous research regarding injury rehabilitation supporting the idea that negative affect, mood
disturbance, and psychological distress tend to dissipate over time, multiple assessment periods
allowed the researchers to examine if psychological responses of injured athletes differed across
time depending on the specific training, or lack thereof received (Tracey, 2003; Brewer et al.,
2007).
Finally, a last important feature of the present investigation was the use of psychological
and emotional response variables designed for specific use within the context of injury
rehabilitation. Specifically, the AISEQ (Milne et al., 2005) used to measure self-efficacy, the
PRSII-19 (Evans et al., 2008), and the adherence measure utilized were all population specific
measures to the athletic injury domain. This was seen as a strength in allowing researchers to not
just assess differences in outcomes assessed by general population measures, such as overall
perceived anxiety, stress, and pain, but also in outcomes specifically designed to assess the
experiences of injured athletes. Noteworthy, due to this being a preliminary study, it was chosen
to include injured athletes from a range of sports displaying an array of injuries to gain an
introductory understanding as to the effects of HRV BFB training in the athletic injury domain,
increase generalizability of findings, and to maximize potential recruitment.
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4.3 Study Limitations
Despite the numerous strengths of this study, there are a few limitations that must be
addressed in terms of (a) the sample that was acquired, (b) equipment and technical procedures,
(c) design/procedural weaknesses, and (d) data analysis.
Sample. The sample for the current study displayed a few characteristics that must be
noted and understood in the interpretation of study findings, as well as for future study
recommendations. First, the current sample consisted of majority males (i.e., 68%), young adult
(Mage) = 20.82, university students who were varsity athletes competing in sport at provincial and
national levels. Results should be interpreted with this in mind and caution should thereby be
upheld when generalizing the study findings to populations of different age groups,
socioeconomic status, and competition levels. Another issue with the current study is that an
overwhelming majority of the injured athletes who took part had prior history of injury and
experience dealing with rehabilitation (i.e.79%). Walker et al. (2007) suggested that after
sustaining an injury and experiencing an extensive rehabilitation period, athletes may
demonstrate greater dedication, focus, and mental toughness than before the injury had occurred.
This may explain some of the current study findings in that a lot of the group mean scores on
psychological outcome measures were truncated to the lower end (i.e., less severe). Future
studies should consider controlling for injury history in order to examine the extent of athletes
psychological response having never been through a rehabilitation process before. A final
limitation pertaining to the sample of the current study was that eligibility criteria required only
that participants (a) had sustained a recent musculoskeletal injury in sport and/or athletic activity,
(b) be currently out of practice and/or training for the sport in which the injury occurred, and (c)
be undergoing rehabilitation for the injury. Due to time constraints in terms of data collection
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and study completion, the nature of injury rehabilitation research, issues surrounding the fact that
one cannot control when individuals sustain an injury, and the delay between injury onset,
initiation of rehabilitation, and actual recruitment notification, it was not possible to control for
and/or match participants across groups based on time since injury. Therefore, although
recruitment was preferred and most desirable immediately post-injury or in the days following,
this was majority of the time not the case as 93% of participants were recruited more than a week
after sustaining the injury. Future studies should consider controlling for time since injury or
examining methods by which participants can be streamlined into the study upon injury onset,
especially given the current injury rehabilitation research, which indicates that negative affect
and mood disturbance improves over time (Tracey, 2003; Brewer et al., 2007). Together, the
inability of the current study to include stricter inclusion criteria regarding injury severity,
history of injury, and time since injury onset was a limitation in that it may have impacted the
levels to which injured athletes perceived psychological outcomes with respect to injury and
rehabilitation and the degree to which the injured athletes were experiencing negative
psychological responses as a result. Future studies that are able to control for any of the above
would be encouraged in order to examine how results may differ from the current study.
Equipment and technical procedures. A few limitations in terms of equipment and
technical procedures were found in the current study. First, due to this being a masters’ thesis
study and funding being an issue, securing the appropriate BFB equipment, desired HRV BFB
software, and laboratory space needed for study completion proved to be challenging.
Nonetheless, eventually issues were resolved, however, not without a few issues that must be
taken into consideration. While the software obtained for the implementation of the
psychophysiological assessment and BFB training sessions met requirements and offered all of
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the essential capabilities needed, there are a number of more advanced software packages
available with multi-display screens and a variety of training modules that would have allowed
for easier and more effective BFB training for those allocated to the HRV BFB Experimental
group. Furthermore, while the training sessions and psychophysiological assessments were
carried out in a controlled setting, construction in the facility where study participation took
place posed some noise and disturbance. This may have partially taken away from the ideal
environment for BFB training. Another limitation with regards to technical procedures is that
psychophysiological assessments were not carried out at the same time each week for each
individual. As much as this was a priority of the researcher, this was simply not possible due to
(a) there being a sole researcher completing data collection, (b) having to revolve around
participant’s schedules, and (c) scheduling multiple participants on a given day. From a
consistency point of view, this would have been seen as a strength in the study design, however,
it was not possible in the current study. Finally, with respect to the psychophysiological
assessment during data collection sessions, participants were asked to refrain from vigorous
exercise, caffeine, nicotine, and/or alcohol beforehand, however controlling for this was not
addressed procedurally. It is therefore possible that participants did not uphold this request.
Design and study procedures. While not all of the following may be viewed as
limitations as much as future directions for research to follow, a few issues with the current study
design will be addressed. First, while it was seen as a strength of the current study including
multiple assessments to gain an understanding of the emotional experience and psychological
responses of injured athletes as they progressed through injury recovery over a three-week
duration, it would have been a strength to include a follow-up assessment post-intervention to
gain insight into long-term effects of the HRV BFB intervention. One limitation of a repeated
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measures design that must be noted is the potential for social desirability on behalf of the
participants and the possible introduction of biases towards self-report measures. Secondly,
previous studies exploring the effectiveness of psychological interventions in athletic injury
rehabilitation have cited that injured athletes perceptions of the delivered psychological
intervention may offer important information for subsequent research (Evans & Hardy, 2002).
The current study unfortunately did not include a post-intervention qualitative assessment
evaluating injured athletes perceptions of HRV BFB, however it is acknowledged that this would
have strengthened the study design and possibly provided an information-rich piece of data.
Likewise, it would have also been an improvement in the study design to have included a short
assessment of the degree to which injured athletes in the experimental group engaged in BFB
practice or the techniques learned through BRB training outside of training sessions. Further,
because recruitment was heavily completed through athletic therapy clinics at Wilfrid Laurier
University, it is possible that crossover effects or social comparison may have occurred between
participants in that those who received the control condition or placebo condition may have
spoken with individuals who were allocated to the intervention and heard of the “true”
experimental procedures. This would have possibly led to a limitation in that by vicarious
experience, individuals may have learned BFB techniques. Previous research regarding
psychological interventions in athletic injury rehabilitation have expressed that these studies
should include measures of rehabilitation outcomes, functional outcomes, and/or treatment
outcomes (Brewer, 1998; Evans & Hardy, 2002; Wesch et al., 2012). Unfortunately, due to the
exploratory nature of this study and broad inclusion criteria (e.g., variation in both sports and
injuries), these were not assessed. A final gap in the present study that should be addressed in
future studies examining the effects of HRV BFB on injured athletes’ psychological responses
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post-injury is the inclusion of a healthy control group to examine how injured athletes compare
on various outcomes to healthy individuals.
Data Analysis. Although the initial recruitment goal of 30 participants was almost
achieved, a larger sample size would have served to increase statistical power and possibly
generate more pronounced effects, especially for those measures bordering significance for either
a time or interaction main effect. Another limitation with regards to data analysis is that due to a
relatively small sample size, and a number of scores on the psychological outcome measures
being truncated to one end, there were a number of instances where either the assumptions of
normality or homogeneity of variance were violated. However, after a number of considerations,
it was decided against utilizing a series of data transformations to attempt to improve the
skewness and kurtosis present. Reasons included (a) the preliminary nature of the study, (b) the
relatively small sample size which considering possible scores on the outcome measures made it
almost impossible to achieve a truly normal distribution, (c) the fact that skewed scores may
have actually demonstrated what was normal in this study, and finally (d) the possibility that
transforming data would actually cause more problems (i.e., the groups and assessment periods
where normality was achieved may actually become violated) and make interpretation of the
results difficult. Nonetheless, this was a study limitation and must be acknowledged.
4.4 Future Directions
A number of future recommendations should be considered with respect to the findings
presented herein. Future directions stemming from the current investigation may be categorized
in terms of (a) psychological skills interventions in injury rehabilitation, (b) BFB specifically and
its use in the athletic injury population, and finally, (c) research pertaining to the use of BFB in
general. For future investigations regarding the use of psychological skills interventions in this
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population, researchers should consider including larger sample sizes, participants matched
across demographic variables, homogenous populations, and randomization of participants into
both a placebo and control group.
Future investigations are encouraged to build off the results found in the current study to
design and implement BFB interventions for injured athletes. Wheat and Larkin (2010)
emphasized the importance of replicating BFB investigations that have been completed because
until studies have been embedded within a larger network of investigations surrounding HRV
BFB’s effects in the same population, each study completed continues to be isolated and a
complete understanding will not be reached. Therefore, researchers should replicate the current
investigation with injured athletes in order to develop a solid foundation of the potential effects
of HRV BFB in this population. Specifically, future recommendations should include
investigations of potential mechanisms by which HRV BFB may lead to beneficial outcomes in
injured athletes. Until this is truly understood, the most effective BFB interventions cannot be
implemented and how this may influence athletes’ psychological responses following injury will
not be fully understood. Second, it would be interesting to investigate whether individuals
naturally higher in HRV display improved psychological responses to sport injury, experience
less mood disturbances, and improved recovery outcomes. Additionally, exploring the effects of
combining HRV BFB with more traditional forms of psychological intervention techniques
could prove to be a viable avenue. Paul and Garg (2012) suggested combining HRV BFB with
relaxation imagery, progressive muscle relaxation, and other forms of mental skills training
interventions so as to generate physiological and psychological domains more consistently and
extensively. Fourth, although recruitment with this population poses difficulty, now that the
exploratory study regarding HRV BFB in the injury population has been completed, future
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researchers are encouraged to investigate the efficacy of BFB with regards to particular injury
types and specific sports. Conducting subsequent investigation where by the time since injury
can be controlled for would be an interesting next step within this field. An approach whereby
participants could be accessed immediately post-injury would allow researchers to gain a true
sense of the temporal patterns in various psychological and physical outcomes pertaining to
injury and rehabilitation. Future investigations are also encouraged to include stricter criteria
regarding injury severity in order to identify potential benefits of BFB when improvements are
there to be made. Inclusion of follow-up assessments in future studies examining this population
would also be recommended to identify any long-term benefits, which may be present.
Furthermore, there is a strong call for future investigations employing the use of HRV BFB in
athletic injury to investigate its potential effects on functional outcomes, recovery outcomes,
direct adherence, return to play statuses, and satisfaction with rehabilitation. It would be
interesting to examine if BFB has the ability to promote functional gains in these athletes.
Finally, inclusion of qualitative methods to get a true sense of athletes’ perceptions of HRV BFB
as a form of psychological skills training intervention would be a strength of future studies.
There is still much research to be done with regards to the use of HRV BFB in general.
Future research is required in order to ascertain the mechanisms by which HRV BFB may lead to
improvements. Continued efforts are also needed to validate methods of measuring and
analyzing HRV and to strengthen protocols for HRV BFB training. Lastly, the potential effects
of HRV BFB over a longer duration than in the present study should be examined in order to
identify whether any long-term benefits are maintained.
4.5 Implications
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With this study being one of the first investigations surrounding the effectiveness of HRV
BFB in the athletic injury domain to improve athletes’ psychological response regarding injury
and rehabilitation, there are a number of practical implications that can be noted with respect to
both BFB and psychological skills training. First, there should be continued efforts to raise
awareness of the psychological impact that an injury can have on athletes. Second,
psychological skills training is a tool all athletes, especially injured athletes should be aware of
and provided with avenues by which to obtain access to. Practitioners should also be educated
on the relative efficacy of psychological intervention techniques in the athletic injury population
and encouraged to employ these using established protocols. Third, psychological rehabilitation
tools should be used in conjunction with physical rehabilitation tools to facilitate optimal
recovery outcomes from both a psychological and physical standpoint. A multidisciplinary
approach should be taken with regards to injury and the subsequent recovery process in order to
address elements of both physical and psychological healing. Fourth, with regards to BFB, this
study emphasized the importance of teaching athletes self-regulatory techniques with respect to
both physiological and emotional arousal. This research speaks to the potential efficacy of HRV
BFB as an available and useful rehabilitation tool, within the athletic injury population, and it
may be a worthwhile technique to utilize to facilitate injured athletes throughout recovery.
Practical implications may be extended through this research, as it speaks to the importance of
educating and enabling injured athletes to be proactive, informed, and involved to achieve an
optimal rehab outcome. Injured athletes should be provided with opportunities to obtain
improved self-regulation of mood states and arousal, effective relaxation techniques, along with
greater adaptability and coping strategies when faced with stressors throughout their recovery
and return to sport.
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Chapter 5: Conclusion
Given the genesis of the research study to evaluate the effectiveness of HRV
biofeedback, a form of psychophysiological skills training intervention, to improve athletes’
psychological response following an injury, the purpose was to examine the effects of HRV BFB
training on self-efficacy, perceived stress and anxiety, pain management, and the psychological
responses of injured athletes. HRV BFB effects on athletes’ physiological indices including
HRV, HR, and respiration rate were also assessed. Participants recruited for this study were
individuals who had sustained a moderate to severe musculoskeletal sports injury (Fuller et al.,
2006), preventing their participation in training and competition for their respective sport.
Eligibility criteria included: (a) participants to be at least 16 years of age, (b) injuries to have
occurred during participation in sport/athletic activity, (c) participants to be out of practice and/or
competition for the sport in which the injury occurred, (d) participants to be undergoing
rehabilitation for the injury (e.g., physiotherapy, massage therapy, athletic therapy, etc.) and (e)
participants to be athletes involved in sport at a competitive level (e.g., regional, rep, varsity,
provincial, national) and/or to be engaging in sport in a competitive environment (e.g., adult
competitive league, training for specific events, road races, competitions, etc.).
This investigation was experimental in nature with a randomized, single-blinded study
design. A 4 (Time: Baseline, Week 1, Week 2, Week 3; assessments across time) x 3 (Group:
HRV BFB Experimental group, HRV BFB Placebo group, Control group; experimental
conditions) mixed model design was utilized to examine the emotional experience and
psychological responses of injured athletes as they progressed through injury recovery. Different
groups were utilized in order to evaluate if athletes' psychological responses regarding injury and
rehabilitation differed depending on the specific training they received. Specifically, there was
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an experimental group, which received the HRV BFB intervention, a placebo group, which
perceived themselves to be receiving a BFB intervention to control for any effects which may
influence the athlete’s psychological responses and physiological indices other than the
intervention training protocol itself, and finally a control group, who received no treatment over
the course of their rehabilitation and recovery. It was hypothesized that injured athletes who
received the HRV BFB intervention would demonstrate significantly greater improvements in
psychological outcomes pertaining to injury and rehabilitation across time than injured athletes
who were not provided with this form of intervention (i.e., HRV BFB Placebo group and Control
group). Specifically, it was hypothesized that the HRV BFB Experimental group would report
significantly greater increases in perceptions of self-efficacy and reorganization, significantly
greater decreases in perceived stress, anxiety, and pain, significantly greater reductions in
psychological responses of devastation, feeling cheated, restlessness, and isolation, and finally,
significantly greater declines in pain catastrophizing and disability due to pain over time,
compared to both the HRV BFB Placebo group and Control group. Further, it was hypothesized
that injured athletes who received the HRV BFB intervention would demonstrate significantly
greater improvements in physiological indices corresponding to BFB training than injured
athletes who were not provided with this form of intervention (i.e., HRV BFB Placebo group and
Control group). Specifically, it was hypothesized that the HRV BFB Experimental group would
demonstrate significant increases in both time-domain (i.e., SDNN) and frequency-domain (i.e.,
Total HRV, LF HRV, HF HRV) measures of HRV, and significant declines in HR and
respiration rate over the duration of the study, compared to both the HRV BFB Placebo group
and Control group.
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Results demonstrated that injured athletes who received the HRV BFB intervention (i.e.,
HRV BFB Experimental group) reported (a) significantly greater reductions in psychological
responses of devastation, reorganization, and isolation, (b) significantly greater declines in
magnification regarding pain, (c) significantly greater improvements in LF HRV during rest, and
(d) significantly greater declines in resting respiration rate across time than injured athletes who
were not provided with this form of intervention (i.e., HRV BFB Placebo group and Control
group). While not reaching statistical significance, injured athletes who received the HRV BFB
intervention also demonstrated (a) greater reductions in the psychological response of
restlessness, (b) greater declines in perceived anxiety, (c) greater improvements in pain
catastrophizing and rumination, (d) greater declines in disability due to pain, and (e) greater
improvements in HRV during rest as measured by SDNN across time than injured athletes who
were not provided with this form of intervention. This preliminary investigation was the first
known sport psychology study regarding psychological skills interventions in injury
rehabilitation to attempt to improve the psychological response of injured athletes with the use of
a HRV BFB intervention. As such, there were a number of relative strengths to the current
study, however, limitations were also discussed with reference to recommendations for future
research in this exciting field of study. Further, with this being an introductory study into the
effectiveness of HRV BFB in the athletic injury population, there are numerous future directions
for other researchers interested in this discipline to branch off of in subsequent investigations.
The present study provides an introductory basis for the use of HRV BFB interventions in the
athletic injury population to improve psychological responses and physiological indices of
injured athletes throughout the rehabilitation and recovery process. In conclusion, it appears that
HRV BFB may hold potential to improve athletes’ psychological response after sustaining an
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injury and that it shows promise as a useful psychological skills intervention for injury
rehabilitation.
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Table 1
Participant Demographic Information based on group
Group
Experimental
Placebo
(n = 9)
(n = 9)
22.0 years
21.0 years
(5.5)
(1.5)
5 Females
1 Female
(55.6%)
(11.1%)
4 Males
8 Males
(44.4%)
(88.9%)
1 (11.1%)
1 (11.1%)

Control
(n = 10)
19.6 years
(1.7)
3 Females
(30%)
7 Males
(70%)
4 (40%)

1

3 (33.3%)

1 (11.1%)

1 (10%)

2

1 (11.1%)

1 (11.1%)

2 (20%)

3

2 (22.2%)

2 (22.2%)

2 (20%)

4

2 (22.2%)

4 (44.4%)

1 (10%)

Soccer

3 (33.3%)

2 (22.2%)

3 (30%)

Football
Hockey
Rugby
Baseball
Basketball
Cheerleading
Ultra running
Varsity/University
Competitive
Recreational
Other
Knee
Hip
Ankle
Shoulder
Other
Less than week
More than week,
less than month
More than month

--2 (22.2%)
1 (11.1%)
--1 (11.1%)
1 (11.1%)
1 (11.1%)
7 (77.8%)
1 (11.1%)

3 (33.3%)
3 (33.3%)
1 (11.1%)
--------9 (100%)
---

3 (30%)
1 (10%)
2 (20%)
1 (10%)
------9 (90%
1 (10%)

1 (11.1%)
4 (44.4%)
1 (11.1%)
2 (22.2%)
--2 (22.2%)
1 (11.1%)
5 (55.6%)

--3 (33.3%)
4 (44.4%)
--1 (11.1%)
1 (11.1%)
1 (11.1%)
5 (55.6%)

--5 (50%)
--3 (30%)
1 (10%)
1 (10%)
--3 (30%)

3 (33.3%)

3 (33.3%)

7 (70%)

Variable
Age (Years)
Mean (SD)
Sex (M/F)

Injury
History (i.e.,
number of
previous
injuries)
Sport

Competition

Injury Type

Time Since
Injury
Onset

	
  

No
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Table 2
Descriptive Statistics for Task Self-Efficacy and Coping Self-Efficacy at Baseline, Week 1, Week
2, and Week 3
Assessment
Variable
Group
n
Baseline
Week 1 Week 2 Week 3 Group
M (SD)
M (SD) M (SD) M (SD) Total
Task
Experimental 9
94.08
92.22
95.56
96.30
94.54
Self(6.41)
(6.87)
(4.71)
(5.12)
Efficacy
Placebo
9
96.67
96.30
95.93
94.82
95.93
(5.53)
(7.35)
(8.13)
(9.44)
Control
10
86.33
88.00
90.00
89.67
88.50
(16.44)
(13.44)
(12.47) (13.47)
Total
28
92.14
92.02
93.69
93.45
--------(11.48)
(10.12)
(9.27)
(10.16)
Coping
Experimental 9
85.28
85.00
86.11
89.58
86.49
Self(13.02)
(12.37)
(11.05) (13.05)
Efficacy
Placebo
9
87.78
86.67
88.89
90.28
88.40
(13.89)
(13.52)
(12.06) (13.14)
Control
10
75.00
73.75
79.75
80.50
77.25
(17.72)
(18.68)
(20.22) (22.91)
Total
28
82.41
81.52
84.73
86.56
--------(15.64)
(15.85)
(15.20) (17.26)
Note. Self-Efficacy scores range from a low of 0% to a high of 100%.
Table 3
Descriptive Statistics for Perceived Stress at Baseline, Week 1, Week 2, and Week 3
Assessment
Variable
Group
n
Baseline
Week 1 Week 2 Week 3 Group
M (SD)
M (SD) M (SD) M (SD) Total
Perceived Experimental 9
17.78
16.33
13.11
10.44
14.42
Stress
(4.94)
(5.36)
(6.86)
(4.77)
Placebo

9

12.00
11.89
12.11
(5.85)
(8.43)
(8.22)
Control
10
16.90
17.50
16.70
(8.23)
(9.86)
(6.48)
Total
28
15.61
15.32
14.07
(6.82)
(8.25)
(7.22)
Note. Perceived stress scores range from a low of 0 to a high of 40.
	
  

11.56
(7.91)
11.80
(7.29)
11.29
(6.58)

11.89
15.73
---------
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Table 4
Descriptive Statistics for Psychological Response to Sport Injury subscales at Baseline, Week 1,
Week 2, and Week 3
Assessment
Variable
Group
n
Baseline Week 1 Week 2 Week 3 Group
M (SD) M (SD) M (SD) M (SD) Total
Devastation
Experimental 9
12.11
9.44
7.33
6.00
8.72
(2.52)
(3.47)
(2.69)
(2.35)

Reorganization

Feeling Cheated

Restlessness

Isolation

Placebo

9

Control

10

Total

28

Experimental

9

Placebo

9

Control

10

Total

28

Experimental

9

Placebo

9

Control

10

Total

28

Experimental

9

Placebo

9

Control

10

Total

28

Experimental

9

Placebo

9

Control

10

Total

28

7.22
(3.42)
10.40
(4.67)
9.93
(4.09)
7.33
(1.66)
9.67
(2.40)
9.70
(2.36)
8.93
(2.37)
9.44
(3.05)
7.33
(3.16)
8.60
(4.20)
8.46
(3.51)
9.78
(2.28)
7.22
(2.91)
9.20
(3.46)
8.75
(3.04)
7.33
(1.94)
5.33
(1.66)
7.30
(2.91)
6.68

8.11
(4.83)
9.30
(4.69)
8.96
(4.26)
9.56
(3.36)
10.44
(3.09)
8.80
(2.15)
9.57
(2.86)
8.11
(2.76)
7.11
(3.86)
9.20
(4.85)
8.18
(3.91)
8.33
(2.35)
7.00
(3.28)
9.60
(5.19)
8.36
(3.87)
7.11
(2.09)
5.22
(1.56)
7.30
(3.47)
6.57

7.44
(3.36)
9.00
(4.32)
7.96
(3.51)
9.89
(2.42)
10.56
(3.05)
9.30
(2.26)
9.89
(2.54)
7.33
(2.40)
7.78
(4.55)
9.10
(4.98)
8.11
(4.09)
7.44
(1.81)
7.11
(3.48)
9.00
(4.90)
7.89
(3.65)
6.11
(3.06)
6.11
(2.76)
8.00
(3.77)
6.79

7.56
(4.22)
8.00
(5.08)
7.21
(4.03)
10.33
(2.35)
10.67
(2.50)
10.40
(2.32)
10.46
(2.30)
6.67
(2.74)
7.78
(5.07)
8.50
(5.19)
7.68
(4.41)
5.78
(2.22)
6.22
(2.99)
8.40
(5.48)
6.86
(3.94)
5.00
(1.66)
5.44
(2.30)
6.80
(3.36)
5.79

7.58
9.18
--------9.28
10.33
9.55
--------7.89
7.50
8.85
--------7.83
6.89
9.05
--------6.39
5.53
7.35
---------
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(2.37)
(2.63)
(3.26)
(2.60)
Note. Psychological Response to Sport Injury subscales range from a low of 4 to a high of 20,
with the exception of reorganization, which ranges from a low of 3 to a high of 15.
Table 5
Descriptive Statistics for Perceived Anxiety at Baseline, Week 1, Week 2, and Week 3
Assessment
Variable
Group
n Baseline Week 1
Week 2
Week 3 Group
M (SD)
M (SD)
M (SD)
M (SD)
Total
Perceived Experimental 9
41.11
38.33
35.67
32.89
37.00
Anxiety
(12.38)
(10.98)
(8.68)
(8.58)
Placebo

9

33.00
33.44
33.67
(12.40)
(13.13)
(13.58)
Control
10 39.90
43.90
43.60
(11.93)
(13.15)
(14.10)
Total
28 38.07
38.75
37.86
(12.30)
(12.79)
(12.76)
Note. Perceived anxiety scores range from a low of 20 to a high of 80.
	
  

34.22
(12.50)
38.20
(15.27)
35.21
(12.30)

33.583
41.40
---------
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Table 6
Descriptive Statistics for Pain Catastrophizing and respective subscales at Baseline, Week 1,
Week 2, and Week 3
Assessment
Variable
Group
n
Baseline Week 1 Week 2 Week 3 Group
M (SD) M (SD) M (SD) M (SD) Total
Pain
Experimental 9
21.78
13.78
14.56
10.11
15.06
Catastrophizing
(9.46)
(8.18)
(9.91)
(9.99)
Total
Placebo
9
15.22
13.56
12.89
12.56
13.56
(13.54)
(13.31) (14.10) (13.56)
Control
10
22.40
18.80
14.00
17.20
18.10
(9.32)
(13.27) (10.38) (13.85)
Total
28
19.89
15.50
13.82
13.43
--------(10.98)
(11.72) (11.16) (12.54)
Rumination
Experimental 9
8.22
5.67
5.78
3.89
5.89
(4.24)
(3.87)
(3.73)
(3.92)
Placebo
9
5.33
5.33
4.78
5.11
5.14
(4.18)
(4.06)
(4.87)
(4.86)
Control
10
8.90
7.30
4.50
6.20
6.73
(4.07)
(4.76)
(4.30)
(4.54)
Total
28
7.54
6.14
5.00
5.11
--------(4.30)
(4.21)
(4.20)
(4.40)
Magnification
Experimental 9
5.33
3.67
3.78
2.67
3.86
(2.78)
(2.60)
(2.28)
(2.06)
Placebo
9
3.44
3.67
3.56
3.33
3.50
(3.78)
(3.81)
(4.00)
(4.00)
Control
10
5.50
4.80
4.50
5.30
5.03
(2.64)
(3.85)
(2.99)
(3.86)
Total
28
4.79
4.07
3.96
3.82
--------(3.12)
(3.40)
(3.07)
(3.51)
Helplessness
Experimental 9
8.22
4.44
5.00
3.56
5.31
(3.80)
(2.51)
(4.18)
(4.85)
Placebo
9
6.44
4.56
4.56
4.11
4.92
(6.02)
(5.94)
(5.55)
(5.30)
Control
10
8.00
6.70
5.00
5.70
6.35
(4.47)
(5.50)
(3.97)
(6.08)
Total
28
7.57
5.29
4.86
4.50
--------(4.73)
(4.85)
(4.43)
(5.34)
Note. Total pain catastrophizing scores range from a low of 0 to a high of 52; rumination
subscale a low of 0 to a high of 16; magnification subscale a low of 0 to a high of 12;
helplessness subscale a low of 0 to a high of 24.
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Table 7
Descriptive Statistics for Perceived Pain at Baseline, Week 1, Week 2, and Week 3
Assessment
Variable
Group
n
Baseline
Week 1 Week 2 Week 3 Group
M (SD)
M (SD) M (SD) M (SD) Total
Perceived Experimental 9
3.22
2.56
1.67
1.78
2.31
Pain
(1.92)
(2.07)
(1.50)
(2.64)
Placebo

9

2.22
2.11
2.56
(2.39)
(2.52)
(2.88)
Control
9
3.00
2.67
2.67
(2.35)
(2.00)
(1.41)
Total
27
2.81
2.44
2.30
(2.19)
(2.14)
(2.02)
Note. Perceived pain scores range from a low of 0 to a high of 10.

2.00
(2.78)
1.56
(1.42)
1.78
(2.28)

2.22
2.47
---------

Table 8
Descriptive Statistics for Pain Disability at Baseline, Week 1, Week 2, and Week 3
Assessment
Variable
Group
n
Baseline
Week 1 Week 2 Week 3 Group
M (SD)
M (SD) M (SD) M (SD) Total
Pain
Experimental 9
24.33
19.89
11.11
8.67
16.00
Disability
(11.30)
(12.16) (10.91) (7.45)
Placebo

9

16.11
15.78
14.00
(15.50)
(16.69) (17.86)
Control
10
26.30
22.10
17.90
(13.22)
(9.97)
(9.10)
Total
28
22.39
19.36
14.46
(13.69)
(12.91) (12.87)
Note. Pain Disability scores range from a low of 0 to a high of 70.

9.56
(16.82)
13.60
(5.70)
10.71
(10.77)

13.86
19.98
---------
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Table 9
Descriptive Statistics for Mean Heart Rate – Rest and Mean Heart Rate – Paced at Baseline,
Week 1, Week 2, and Week 3
Assessment
Variable
Group
n
Baseline
Week 1 Week 2 Week 3 Group
M (SD)
M (SD) M (SD) M (SD) Total
Mean
Experimental 9
67.98
68.81
72.09
76.46
71.33
Heart
(7.48)
(4.22)
(6.37)
(8.08)
Rate Rest
Placebo
9
64.33
68.07
69.41
67.31
67.28
(5.08)
(12.06)
(10.47) (6.34)
Control
9
74.10
70.40
70.18
74.85
72.38
(12.56)
(11.39)
(15.40) (13.46)
Total
27
68.80
69.09
70.56
72.87
--------(9.52)
(9.54)
(10.98) (10.23)
Mean
Experimental 9
70.04
68.58
70.76
75.66
71.26
Heart
(7.10)
(5.02)
(6.95)
(6.66)
Rate Placebo
9
65.58
69.70
69.61
67.76
68.16
Paced
(4.86)
(12.28)
(10.12) (7.14)
Control
7
74.96
70.96
71.77
75.07
73.19
(12.04)
(10.41)
(14.00) (13.79)
Total
25
69.82
69.65
70.63
72.65
--------(8.68)
(9.31)
(10.00) (9.67)
Note. Mean HR is measured in beats per minute (bpm).
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Table 10
Descriptive Statistics for SDNN – Rest and SDNN – Paced at Baseline, Week 1, Week 2, and
Week 3
Assessment
Variable
Group
n
Baseline
Week 1 Week 2 Week 3 Group
M (SD)
M (SD) M (SD) M (SD) Total
SDNN Experimental 9
62.52
109.11
101.43 87.41
90.12
Rest
(27.96)
(39.24)
(36.66) (31.37)
Placebo

9

88.28
100.44
83.99
92.93
91.41
(33.23)
(55.09)
(36.97) (33.79)
Control
9
71.61
76.93
84.94
76.38
77.46
(36.09)
(30.99)
(25.27) (25.81)
Total
27
74.14
95.49
90.12
85.57
--------(33.15)
(43.53)
(33.13) (30.14)
SDNN –
Experimental 9
99.23
104.36
98.38
82.82
96.20
Paced
(26.19)
(32.30)
(29.68) (24.18)
Placebo
9
115.92
130.27
116.46 117.95 120.15
(44.05)
(46.65)
(43.14) (33.59)
Control
7
98.72
122.52
124.19 103.07 112.13
(43.20)
(46.61)
(48.18) (40.32)
Total
25
105.10
118.77
112.12 101.13 --------(37.56)
(41.81)
(40.18) (34.79)
Note. SDNN = standard deviation of normal-to-normal intervals; measured in milliseconds (ms).
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Table 11
Descriptive Statistics for Total HRV – Rest and Total HRV – Paced at Baseline, Week 1, Week 2,
and Week 3
Assessment
Variable
Group
n
Baseline
Week 1
Week 2
Week 3
Group
M (SD)
M (SD)
M (SD)
M (SD)
Total
Total
Experimental 9 4373.99
12991.54
11173.84
8094.16
9158.38
HRV (4003.15) (8815.61) (8130.79) (5525.49)
Rest
Placebo
9 8581.49
12917.80
7504.58
9091.39
9523.82
(6289.67) (13493.82) (6385.24) (6749.95)
Control
9 5504.22
6313.67
7067.98
5842.37
6182.06
(5760.63) (5130.24) (4202.07) (4649.94)
Total
27 6153.23
10741.00
8582.14
7675.97
--------(5531.42) (9910.33) (6468.40) (5655.43)
Total
Experimental 9 9893.85
11662.33
10329.41
6766.24
9662.96
HRV (5071.20) (7573.81) (5394.35) (3382.51)
Paced
Placebo
9 15138.19
18831.65
14834.00
14628.40 15858.06
(12525.72) (13318.33) (9680.58) (7974.81)
Control
7 11197.02
16399.34
16872.11
11639.24 14026.93
(7158.39) (11104.88) (11166.32) (8088.80)
Total
25 12146.70
15569.65
13783.02
10961.06 --------(8899.61) (10908.37) (8931.93) (7290.17)
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Table 12
Descriptive Statistics for LF HRV – Rest and LF HRV – Paced at Baseline, Week 1, Week 2, and
Week 3
Assessment
Variable
Group
n
Baseline
Week 1
Week 2
Week 3
Group
M (SD)
M (SD)
M (SD)
M (SD)
Total
LF HRV Experimental 9
1917.23
10535.90 7764.45
6030.91
6562.12
– Rest
(2192.45) (7673.33) (4229.39) (4375.39)
Placebo

9

4046.28
5436.61
3258.58
4819.40
4390.22
(5943.67) (8051.19) (4724.04) (6141.06)
Control
9
2035.99
3080.32
2913.88
2758.06
2697.06
(1776.63) (4483.46) (3880.51) (4302.20)
Total
27 2666.50
6350.94
4645.64
4536.13
--------(3782.99) (7368.98) (4698.40) (5008.49)
LF HRV Experimental 9
7518.97
7305.14
7591.59
4636.20
6762.98
- Paced
(3724.06) (4705.26) (4193.89) (2442.96)
Placebo
9
9654.77
13409.81 9980.31
10686.00 10932.72
(6375.36) (9488.48) (7171.43) (7108.84)
Control
7
8292.53
11556.51 12121.95 8374.81
10086.45
(5144.29) (8587.64) (7663.42) (6366.17)
Total
25 8504.45
10693.21 9720.03
7860.94
--------(5065.64) (7944.60) (6410.54) (5994.67)
Note. LF HRV = low frequency; measured in ms^2/Hz; HRV in frequency band of 0.04-0.15 Hz.

HEART RATE VARIABILITY BIOFEEDBACK

111

Table 13
Descriptive Statistics for HF HRV – Rest and HF HRV – Paced at Baseline, Week 1, Week 2, and
Week 3
Assessment
Variable
Group
n
Baseline
Week 1
Week 2
Week 3 Group
M (SD)
M (SD)
M (SD)
M (SD)
Total
HF HRV Experimental 9
1534.71
1149.07
1461.31
772.17
1229.32
- Rest
(1537.12) (1102.91) (2202.09) (1147.13)
Placebo

9

2521.14
4026.19
1739.16
1989.98
2569.12
(2827.32) (5632.19) (1842.60) (1331.68)
Control
9
1545.27
1357.18
1497.74
926.04
1331.56
(2748.84) (992.79) (944.34) (567.80)
Total
27
1867.04
2177.48
1566.07
1229.40
--------(2394.53) (3495.73) (1681.34) (1163.71)
HF HRV Experimental 9
831.07
1362.45
988.65
763.60
986.44
- Paced
(639.84)
(1479.65) (906.11) (620.53)
Placebo
9
1601.82
2239.27
1708.43
1252.35
1700.47
(1243.66) (1923.10) (1160.03) (1059.45)
Control
7
1506.44
2362.43
2175.48
1464.51
1877.22
(1527.77) (1609.57) (1843.50) (1077.33)
Total
25
1297.64
1958.10
1580.08
1135.81
--------(1168.16) (1679.47) (1346.33) (938.73)
Note. HF HRV = high frequency; measured in ms^2/Hz; HRV in frequency band of 0.15-0.4 Hz.
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Table 14
Descriptive Statistics for Mean Respiration Rate – Rest and Mean Respiration Rate – Paced at
Baseline, Week 1, Week 2, and Week 3
Assessment
Variable
Group
n
Baseline Week 1
Week 2 Week 3 Group
M (SD)
M (SD)
M (SD) M (SD) Total
Respiration Experimental 9
12.59
6.61
6.09
6.67
7.99
Rate – Rest
(2.53)
(1.04)
(1.14)
(1.32)
Placebo

9

12.50
11.35
(4.71)
(3.08)
Control
9
13.82
12.84
(3.41)
(3.98)
Total
27
12.97
10.27
(3.57)
(3.93)
Respiration Experimental 9
7.61
6.65
Rate (2.08)
(0.75)
Paced
Placebo
9
7.25
7.09
(1.45)
(1.00)
Control
8
7.73
7.03
(2.12)
(1.05)
Total
26
7.52
6.92
(1.83)
(0.92)
Note. Respiration rate = average breaths per minute.

12.51
(5.25)
12.55
(3.87)
10.38
(4.80)
6.81
(0.93)
6.99
(1.50)
6.76
(0.76)
6.86
(1.08)

12.14
(4.71)
12.53
(3.68)
10.45
(4.35)
6.61
(0.99)
7.14
(1.69)
7.22
(1.54)
6.98
(1.40)

12.12
12.93
--------6.92
7.12
7.19
---------
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Allocated to
HRV Placebo Group (n = 11)
Received allocated intervention
& provided complete data (n = 9)
Dropped out of study (n = 2)

	
  

Analysis
(n = 9)

Analysis
(n = 9)

Figure 1. Participant Recruitment Flow Chart.
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& provided complete data (n = 10)
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Analysis
(n = 10)
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1. Study Details

2. Informed Consent

3. Demographics
Questionnaire

4. Self-report
Questionnaires

5. Introduction to
setting, equipment,
etc.

6.
Psychophysiological
Assessment

HRV BFB Experimental Group Protocol:

HRV BFB Placebo Group Protocol:
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Control Group Protocol:

Figure 2. Illustrated Overview of Research Protocol.
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Figure 3. Image of respiration belt placement used in biofeedback procedures.

Figure 4. Image of ECG electrode placement used in biofeedback procedures.
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Figure 5. AD Instruments LabChart Pro 7.0 software display screen used for both biofeedback
training sessions and psychophysiological assessments.
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Figure 6. A graphic depiction of the interaction effect demonstrated for perceptions of task selfefficacy across assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB
Placebo group (n=9), and Control group (n=10) injured athletes.
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Figure 7. A graphic depiction of the interaction effect demonstrated for perceptions of coping
self-efficacy across assessments (time) between the HRV BFB Experimental group (n=9), HRV
BFB Placebo group (n=9), and Control group (n=10) injured athletes.
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Figure 8. A graphic depiction of the interaction effect demonstrated for perceived stress across
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group
(n=9), and Control group (n=10) injured athletes.
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Figure 9. A graphic depiction of the interaction effect demonstrated for psychological response
to sport injury subscale of devastation across assessments (time) between the HRV BFB
Experimental group (n=9), HRV BFB Placebo group (n=9), and Control group (n=10) injured
athletes.
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Figure 10. A graphic depiction of the interaction effect demonstrated for psychological response
to sport injury subscale of reorganization across assessments (time) between the HRV BFB
Experimental group (n=9), HRV BFB Placebo group (n=9), and Control group (n=10) injured
athletes.
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Figure 11. A graphic depiction of the interaction effect demonstrated for psychological response
to sport injury subscale of feeling cheated across assessments (time) between the HRV BFB
Experimental group (n=9), HRV BFB Placebo group (n=9), and Control group (n=10) injured
athletes.
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Figure 12. A graphic depiction of the interaction effect demonstrated for psychological response
to sport injury subscale of restlessness across assessments (time) between the HRV BFB
Experimental group (n=9), HRV BFB Placebo group (n=9), and Control group (n=10) injured
athletes.
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Figure 13. A graphic depiction of the interaction effect demonstrated for psychological response
to sport injury subscale of isolation across assessments (time) between the HRV BFB
Experimental group (n=9), HRV BFB Placebo group (n=9), and Control group (n=10) injured
athletes.
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Figure 14. A graphic depiction of the interaction effect demonstrated for perceived anxiety
across assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo
group (n=9), and Control group (n=10) injured athletes.
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Figure 15. A graphic depiction of the interaction effect demonstrated for total pain
catastrophizing across assessments (time) between the HRV BFB Experimental group (n=9),
HRV BFB Placebo group (n=9), and Control group (n=10) injured athletes.
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Figure 16. A graphic depiction of the interaction effect demonstrated for the pain catastrophizing
subscale of rumination across assessments (time) between the HRV BFB Experimental group
(n=9), HRV BFB Placebo group (n=9), and Control group (n=10) injured athletes.
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Figure 17. A graphic depiction of the interaction effect demonstrated for the pain catastrophizing
subscale of magnification across assessments (time) between the HRV BFB Experimental group
(n=9), HRV BFB Placebo group (n=9), and Control group (n=10) injured athletes.
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Figure 18. A graphic depiction of the interaction effect demonstrated for the pain catastrophizing
subscale of helplessness across assessments (time) between the HRV BFB Experimental group
(n=9), HRV BFB Placebo group (n=9), and Control group (n=10) injured athletes.
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Figure 19. A graphic depiction of the interaction effect demonstrated for perceived pain across
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group
(n=9), and Control group (n=9) injured athletes.
	
  

	
  

HEART RATE VARIABILITY BIOFEEDBACK

132

Figure 20. A graphic depiction of the interaction effect demonstrated for pain disability across
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group
(n=9), and Control group (n=10) injured athletes.
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Figure 21. A graphic depiction of the main effect demonstrated for rehabilitation adherence –
frequency between the HRV BFB Experimental group (n=9), HRV BFB Placebo group (n=8),
and Control group (n=9) injured athletes.
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Figure 22. A graphic depiction of the main effect demonstrated for rehabilitation adherence –
duration between the HRV BFB Experimental group (n=9), HRV BFB Placebo group (n=9), and
Control group (n=10) injured athletes.
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Figure 23. A graphic depiction of the main effect demonstrated for rehabilitation adherence –
quality between the HRV BFB Experimental group (n=9), HRV BFB Placebo group (n=9), and
Control group (n=10) injured athletes.
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Figure 24. A graphic depiction of the interaction effect demonstrated for mean HR – rest across
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group
(n=9), and Control group (n=9) injured athletes.
	
  
	
  
	
  
	
  
	
  
	
  
	
  

HEART RATE VARIABILITY BIOFEEDBACK

137

	
  
Figure 25. A graphic depiction of the interaction effect demonstrated for mean HR – paced
across assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo
group (n=9), and Control group (n=7) injured athletes.
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Figure 26. A graphic depiction of the interaction effect demonstrated for SDNN – rest across
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group
(n=9), and Control group (n=9) injured athletes.
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Figure 27. A graphic depiction of the interaction effect demonstrated for SDNN – paced across
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group
(n=9), and Control group (n=7) injured athletes.
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Figure 28. A graphic depiction of the interaction effect demonstrated for total HRV – rest across
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group
(n=9), and Control group (n=9) injured athletes.
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Figure 29. A graphic depiction of the interaction effect demonstrated for total HRV – paced
across assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo
group (n=9), and Control group (n=7) injured athletes.
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Figure 30. A graphic depiction of the interaction effect demonstrated for LF HRV – rest across
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group
(n=9), and Control group (n=9) injured athletes.
	
  
	
  
	
  
	
  
	
  
	
  

	
  

HEART RATE VARIABILITY BIOFEEDBACK

143

	
  

	
  
Figure 31. A graphic depiction of the interaction effect demonstrated for LF HRV – paced across
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group
(n=9), and Control group (n=7) injured athletes.
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Figure 32. A graphic depiction of the interaction effect demonstrated for HF HRV – rest across
assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo group
(n=9), and Control group (n=9) injured athletes.
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Figure 33. A graphic depiction of the interaction effect demonstrated for HF HRV – paced
across assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB Placebo
group (n=9), and Control group (n=7) injured athletes.
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Figure 34. A graphic depiction of the interaction effect demonstrated for mean respiration rate –
rest across assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB
Placebo group (n=9), and Control group (n=9) injured athletes.
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Figure 35. A graphic depiction of the interaction effect demonstrated for mean respiration rate –
paced across assessments (time) between the HRV BFB Experimental group (n=9), HRV BFB
Placebo group (n=9), and Control group (n=8) injured athletes.
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Appendix A
Wilfrid Laurier
University

Founded 1911
Letter of Information
Effects of a Heart Rate Variability Biofeedback Intervention on Athletes’ Psychological Response
Following Injury
Lead researcher: Scott Rollo
Supervisor: Jill Tracey, Ph.D.
We are conducting a research study and would greatly appreciate it if you would be willing to assist us.
The purpose of this letter is to provide you with some details regarding the proposed study.
The purpose of this study is to evaluate the effectiveness of heart rate variability biofeedback (HRV
BFB), a form of psychophysiological skills training intervention, to improve athletes’ psychological
responses following an injury. Further, to examine the effects of HRV BFB training on self-efficacy,
perceived stress and anxiety, pain management, and the psychological responses of injured athletes. HRV
BFB effects on athletes’ physiological indices including heart rate variability, heart rate, and respiration
rate will also be assessed.
A potential contribution of this research is to assess whether using biofeedback in rehabilitation can serve
as a helpful intervention for those recovering from an injury. While other techniques have been used
within sport psychology, the use of biofeedback is a novel and new approach within the athletic
rehabilitation setting. If successful, this research could speak to the effectiveness of biofeedback as an
available and useful rehabilitation tool within the athletic injury population. Biofeedback has the
potential of improving the injured athletes’ psychological response and reducing emotional distress
throughout their recovery. Participants may be given the opportunity to obtain improved self-regulation
of mood states and arousal, effective relaxation techniques, and greater ability to cope when faced with
stressors regarding rehabilitation.
Participants will be randomly assigned to one of three study groups. These groups involve a HRV BFB
experimental group, HRV BFB placebo group, and one group that will receive no training and act as a
control group. Participants assigned to either the HRV BFB experimental group or HRV BFB placebo
group will receive six BFB training sessions over a 3-week duration. Participants assigned to the control
group will receive no training. Psychological outcome questionnaires (to measure: self-efficacy,
perceived stress, anxiety, pain management & psychological responses of injured athletes) and a
physiological assessment (to measure: HR, HRV, & respiratory rate) will be administered on four
occasions over a 3-week duration for all participants. Data will be collected to examine the emotional
experience and psychological responses of injured athletes as they progress through injury recovery.
Different groups are required in order to evaluate if athletes' psychological responses regarding injury and
rehabilitation differ depending on the specific training they receive. It is important to conceal this
information (i.e., true purpose, study objectives, procedures), as we want behaviour to remain as
natural as possible. Initial deception and/or concealment is neither arbitrary nor capricious.
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This project has been reviewed and approved by the University Research Ethics Board. If you have any
questions and/or ethical concerns surrounding this study, you may contact Dr. Robert Basso, Chair,
University Research Ethics Board, Wilfrid Laurier University, (519) 884-1970, extension 5225 or
rbasso@wlu.ca.
In order to assist us in the recruitment process, we are asking that you provide your clients, who you
know to be injured athletes, with a recruitment poster. Your client’s participation is completely voluntary
and it is their decision as to whether they contact myself, Scott Rollo to take part in the study. If you are
willing to provide assistance by helping with recruitment for our research project, please contact either
Scott Rollo or Dr. Jill Tracey, by phone or email ASAP.
Thank you.
Scott Rollo MSc(c), BA
Department of Kinesiology & Physical Education
Wilfrid Laurier University
Waterloo, ON N2L 3C5
roll2100@mylaurier.ca
(226) 678-4926
Dr. Jill Tracey
Associate Professor/Sport Psychology Consultant
Wilfrid Laurier University
Department of Kinesiology & Physical Education
Waterloo, ON N2L 3C5
jtracey@wlu.ca
(519) 884-0710 ext. 4216
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Appendix C
Wilfrid Laurier
University

Founded 1911
Letter of Information
An Examination of Athletes’ Psychological Response Following Injury
Lead researcher: Scott Rollo
Supervisor: Jill Tracey, Ph.D.
You are invited to participate in a study as a varsity athlete who has sustained an injury and is currently in
the recovery process. The purpose of this study is to examine the psychological response of athletes
regarding the injury and rehabilitation process. We are interested in assessing various psychological
outcomes and physiological measures (i.e., heart rate variability, respiration, self-efficacy, stress, anxiety,
pain management & psychological responses of injured athletes) as you progress through different phases
of injury recovery.
You will be asked to complete a series of questionnaires and physiological assessments over three weeks.
The questionnaires should take approximately 15-20 minutes to complete. The physiological assessment
will also be 20 minutes in duration. Data will be collected to examine the emotional experience and
psychological responses of injured athletes as they progress through injury recovery. All study
participants will receive a $10 gift certificate to Tim Hortons at study completion.
This project has been reviewed and approved by the University Research Ethics Board (REB #3670).
Any results found will be for the use of research only, and will have no impact or influence on your
athletic therapist’s recommendations to return to play. If you are interested in participating, please
contact myself, Scott Rollo by email at roll2100@mylaurier.ca or provide your contact information
below.
Thank you.
Scott Rollo
MSc Graduate Student
Department of Kinesiology & Physical Education
Wilfrid Laurier University
Waterloo, ON N2L 3C5
roll2100@mylaurier.ca
(226) 678-4926
------------------------------------------------------------------------------------------------------------------------------Potential Participant Name: _____________________________________________________
Email Address: _______________________________________________________________
Phone Number (optional): _______________________________________________________
Injury: _______________________________________________________________________
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Appendix D
Proposed Recruitment Screening Email
Hello (Insert Name),
Thank you for your interest in participating in this research study. Please confirm your eligibility
to participate in this study by ensuring you meet all criteria listed below:
(A) You are at least 16 years of age
(B) You recently sustained your injury during participation in sport/athletic activity
(C) Your injury is not a concussion and/or head injury
(D) You are currently out of practice and/or competition for the sport in which your injury
occurred
(E) You are currently undergoing rehabilitation for your injury
(F) You are an athlete at a competitive level (i.e., regional, rep, varsity, provincial, national,
etc.) and/or engage in your sport in a competitive environment (i.e., adult competitive
league, training for specific events, road races, competitions, etc.)
(G) You have no known heart condition (i.e., heart abnormalities and/or cardiac arrhythmias)
(H) You have no history/current diagnosis of coronary artery disease, heart disease, heart
failure, high blood pressure, and/or chronic low blood pressure
(I) You are not currently receiving any formal training in any form of relaxation,
biofeedback, or breathing technique.
If you meet all of the above criteria, you are deemed eligible for participation in this study.
If participation is still of interest to you, please respond to this email with a few dates and times,
according to your schedule, when you would be available to meet for a baseline assessment
session.
This baseline session will be held in the Physiology Laboratory in the Athletic Complex at
Wilfrid Laurier University. At this time, you will be provided with an informed consent to sign if
you wish to continue with study participation, and study details in greater length.
If you have any additional questions or require clarification of any kind, please do not hesitate to
include in any email response you provide.
Look forward to hearing from you!
Scott Rollo
Department of Kinesiology & Physical Ed.
Wilfrid Laurier University
Waterloo, ON, Canada, N2L 3C5
roll2100@mylaurier.ca
BA. Hon. Kinesiology 2012
University of Western Ontario
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Appendix E
INFORMED CONSENT
WILFRID LAURIER UNIVERSITY
Effects of a Heart Rate Variability Biofeedback Intervention on Athletes’ Psychological
Response Following Injury
You are invited to participate in a research study. As part of the thesis requirement for
completion of a Master’s of Science degree at Wilfrid Laurier, Scott Rollo, a graduate student in
the Department of Kinesiology and Physical Education, and Dr. Jill Tracey, an associate
professor in the Department of Kinesiology and Physical Education are completing a research
study. The purpose of this study is to evaluate the effectiveness of biofeedback, a form of
psychological skills training intervention during your injury rehabilitation process. We will be
assessing various psychological outcomes/physiological measures (i.e., heart rate variability,
respiration, self-efficacy, stress, anxiety, pain management & psychological responses of injured
athletes) as you progress through injury recovery.
INFORMATION
Your participation in this study is strictly voluntary. You may withdraw from the study at
anytime during the 3 weeks if you have initially chosen to participate. You are being asked to
complete a series of questionnaires, in addition to a physiological assessment on four occasions
and to participate in a biofeedback intervention. The questionnaires should take approximately
15-20 minutes to complete. The physiological assessment will also be 20 minutes in duration. If
for any reason you are uncomfortable with a question you do not have to respond. You may also
withdraw from the study at any time without penalty and without loss of benefits to which you
are otherwise entitled. The biofeedback portion of the study will involve meeting with Scott in
the physiology lab at Wilfrid Laurier University on 9 occasions (3x/week). During the
intervention sessions, you will be guided through a biofeedback training protocol and instructed
to practice paced breathing using a pursed lips abdominal procedure. Heart rate and respiration
will be monitored throughout. Additionally, your health care professionals will not be aware of
your participation in this study and therefore your decision to participate or not will have no
effect on your ongoing rehabilitation outside of this study. Study objectives cannot be fully
described at this time, but at the conclusion of participation, an explanation will be provided.
RISKS AND BENEFITS
This project will add to the body of research in this area of sports psychology and injury
rehabilitation. While other techniques have been used within sport psychology, the use of
biofeedback is a novel and new approach within the athletic injury population. A potential
benefit is to assess whether using biofeedback in athletic rehabilitation can serve as a helpful
intervention for those recovering from an injury. The only foreseeable risks to you as a
participant would be potential boredom during completion of the questionnaires, physiological
assessment, and/or biofeedback training sessions.
CONFIDENTALITY
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All foreseeable efforts will be made to insure your confidentiality during the data collection,
publication and presentation of the data. The information you provide will be accessible only to
Dr. Jill Tracey and Scott Rollo. It is expected that there will be approximately 30 participants.
You will not be identified by name in any of the data presentation. Additionally, your name will
not be used in any publication or presentation of this research instead participant number will be
assigned. Also, neither your health care professionals and/or coaches will know whether you
have participated in this study or the information you have provided unless you choose to discuss
it with them. Your data will be retained for 5 years in a locked office at Wilfrid Laurier
University accessible only to Dr. Jill Tracey and Scott Rollo as required by the Research Ethics
Board.
COMPENSATION
If you participate in the study you will receive a $10 gift certificate to Tim Hortons at study
completion.
CONTACT
If you have any questions at any time about this study of the procedures (or you have
experienced adverse effects as a result of participating in this study) you may contact Dr. Jill
Tracey at Wilfrid Laurier University at 519-884-0710 extension 4216. This project has been
reviewed and approved by the University Research Ethics Board. If you feel you have not been
treated according to the description in this form, or your rights as a participant in research have
been violated during the course of this project you may contact Dr. Robert Basso, Chair,
University Research Ethics Board, Wilfrid Laurier University, (519) 884-1970, extension 5225
or rbasso@wlu.ca.
FEEDBACK AND PUBLICATION
You can receive feedback regarding the study’s findings by contacting the researcher, Scott
Rollo. The information from this research project will be submitted, upon completion, for
publication in various sports psychology and sport rehabilitation journals as well as presented at
relevant conferences.
CONSENT
I have read and understand the above information. I have received a copy of this form. I agree to
participate in this study.
Participant’s signature____________________________ Date______________________
Investigator’s signature___________________________ Date ______________________
If you agree to be contacted to participate in this research study please provide your email
address and/or phone number for correspondence with the researcher and to allow confirmation
of scheduled sessions.
______________________________________ ______________________________________
Email Address
Phone Number
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Appendix F
INFORMED CONSENT
WILFRID LAURIER UNIVERSITY
Effects of a Heart Rate Variability Biofeedback Intervention on Athletes’ Psychological
Response Following Injury
You are invited to participate in a research study. As part of the thesis requirement for
completion of a Master’s of Science degree at Wilfrid Laurier, Scott Rollo, a graduate student in
the Department of Kinesiology and Physical Education, and Dr. Jill Tracey, an associate
professor in the Department of Kinesiology and Physical Education are completing a research
study. The purpose of this study is to evaluate the effectiveness of biofeedback, a form of
psychological skills training intervention during your injury rehabilitation process. We will be
assessing various psychological outcomes/physiological measures (i.e., heart rate variability,
respiration, self-efficacy, stress, anxiety, pain management & psychological responses of injured
athletes) as you progress through injury recovery.
INFORMATION
Your participation in this study is strictly voluntary. You may withdraw from the study at
anytime during the 3 weeks if you have initially chosen to participate. You are being asked to
complete a series of questionnaires, in addition to a physiological assessment on four occasions
and to participate in a biofeedback intervention. The questionnaires should take approximately
15-20 minutes to complete. The physiological assessment will also be 20 minutes in duration. If
for any reason you are uncomfortable with a question you do not have to respond. You may also
withdraw from the study at any time without penalty and without loss of benefits to which you
are otherwise entitled. The biofeedback portion of the study will involve meeting with Scott in
the physiology lab at Wilfrid Laurier University on 9 occasions (3x/week). During the
intervention sessions, you will be instructed to relax and continue your normal resting breathing
pattern. Heart rate and respiration will be monitored throughout. Additionally, your health care
professionals will not be aware of your participation in this study and therefore your decision to
participate or not will have no effect on your ongoing rehabilitation outside of this study. Study
objectives cannot be fully described at this time, but at the conclusion of participation, an
explanation will be provided.
RISKS AND BENEFITS
This project will add to the body of research in this area of sports injury psychology and
rehabilitation. While other techniques have been used within sport psychology, the use of
biofeedback is a novel and new approach within the athletic injury population. A potential
benefit is to assess whether using biofeedback in athletic rehabilitation can serve as a helpful
intervention for those recovering from an injury. The only foreseeable risks to you as a
participant would be potential boredom during completion of the questionnaires, physiological
assessment, and/or biofeedback training sessions.
CONFIDENTALITY
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All foreseeable efforts will be made to insure your confidentiality during the data collection,
publication and presentation of the data. The information you provide will be accessible only to
Dr. Jill Tracey and Scott Rollo. It is expected that there will be approximately 30 participants.
You will not be identified by name in any of the data presentation. Additionally, your name will
not be used in any publication or presentation of this research instead participant number will be
assigned. Also, neither your health care professionals and/or coaches will know whether you
have participated in this study or the information you have provided unless you choose to discuss
it with them. Your data will be retained for 5 years in a locked office at Wilfrid Laurier
University accessible only to Dr. Jill Tracey and Scott Rollo as required by the Research Ethics
Board.
COMPENSATION
If you participate in the study you will receive a $10 gift certificate to Tim Hortons at study
completion.
CONTACT
If you have any questions at any time about this study of the procedures (or you have
experienced adverse effects as a result of participating in this study) you may contact Dr. Jill
Tracey at Wilfrid Laurier University at 519-884-0710 extension 4216. This project has been
reviewed and approved by the University Research Ethics Board. If you feel you have not been
treated according to the description in this form, or your rights as a participant in research have
been violated during the course of this project you may contact Dr. Robert Basso, Chair,
University Research Ethics Board, Wilfrid Laurier University, (519) 884-1970, extension 5225
or rbasso@wlu.ca.
FEEDBACK AND PUBLICATION
You can receive feedback regarding the study’s findings by contacting the researcher, Scott
Rollo. The information from this research project will be submitted, upon completion, for
publication in various sports psychology and sport rehabilitation journals as well as presented at
relevant conferences.
CONSENT
I have read and understand the above information. I have received a copy of this form. I agree to
participate in this study.
Participant’s signature____________________________ Date______________________
Investigator’s signature___________________________ Date ______________________
If you agree to be contacted to participate in this research study please provide your email
address and/or phone number for correspondence with the researcher and to allow confirmation
of scheduled sessions.
______________________________________ ______________________________________
Email Address
Phone Number
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Appendix G
INFORMED CONSENT
WILFRID LAURIER UNIVERSITY
An Examination of Athletes’ Psychological Response Following Injury
You are invited to participate in a research study. As part of the thesis requirement for
completion of a Master’s of Science degree at Wilfrid Laurier, Scott Rollo, a graduate student in
the Department of Kinesiology and Physical Education, and Dr. Jill Tracey, an associate
professor in the Department of Kinesiology and Physical Education are completing a research
study. The purpose of this study is to examine the psychological response of athletes regarding
the injury and rehabilitation process as they progress through injury recovery. We will be
assessing various psychological outcomes and physiological measures (i.e., heart rate variability,
respiration, self-efficacy, stress, anxiety, pain management & psychological responses of injured
athletes) as you progress through different phases of injury rehabilitation.
INFORMATION
Your participation in this study is strictly voluntary. You may withdraw from the study at
anytime during the 3 weeks if you have initially chosen to participate. You are being asked to
complete a series of questionnaires, in addition to a physiological assessment on four occasions.
The questionnaires should take approximately 15-20 minutes to complete. The physiological
assessment will also be 20 minutes in duration. If for any reason you are uncomfortable with a
question you do not have to respond. You may also withdraw from the study at any time without
penalty and without loss of benefits to which you are otherwise entitled. Additionally, your
health care professionals will not be aware of your participation in this study and therefore your
decision to participate or not will have no effect on your ongoing rehabilitation outside of this
study. Study objectives cannot be fully described at this time, but at the conclusion of
participation, an explanation will be provided.
RISKS AND BENEFITS
This project will add to the body of research in this area of sports injury psychology and
rehabilitation. A potential benefit from this study is to gain a better understanding of the
psychological recovery from athletic injury, and consequently, to better assist injured athletes
during their rehabilitation process. The only foreseeable risks to you as a participant would be
potential boredom during completion of the questionnaires and/or physiological assessment.
CONFIDENTALITY
All foreseeable efforts will be made to insure your confidentiality during the data collection,
publication and presentation of the data. The information you provide will be accessible only to
Dr. Jill Tracey and Scott Rollo. It is expected that there will be approximately 30 participants.
You will not be identified by name in any of the data presentation. Additionally, your name will
not be used in any publication or presentation of this research instead participant number will be
assigned. Also, neither your health care professionals and/or coaches will know whether you
have participated in this study or the information you have provided unless you choose to discuss
it with them. Your data will be retained for 5 years in a locked office at Wilfrid Laurier
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University accessible only to Dr. Jill Tracey and Scott Rollo as required by the Research Ethics
Board.
COMPENSATION
If you participate in the study you will receive a $10 gift certificate to Tim Hortons at study
completion.
CONTACT
If you have any questions at any time about this study of the procedures (or you have
experienced adverse effects as a result of participating in this study) you may contact Dr. Jill
Tracey at Wilfrid Laurier University at 519-884-0710 extension 4216. This project has been
reviewed and approved by the University Research Ethics Board. If you feel you have not been
treated according to the description in this form, or your rights as a participant in research have
been violated during the course of this project you may contact Dr. Robert Basso, Chair,
University Research Ethics Board, Wilfrid Laurier University, (519) 884-1970, extension 5225
or rbasso@wlu.ca.
FEEDBACK AND PUBLICATION
You can receive feedback regarding the study’s findings by contacting the researcher, Scott
Rollo. The information from this research project will be submitted, upon completion, for
publication in various sports psychology and sport rehabilitation journals as well as presented at
relevant conferences.
CONSENT
I have read and understand the above information. I have received a copy of this form. I agree to
participate in this study.
Participant’s signature____________________________ Date______________________
Investigator’s signature___________________________ Date ______________________
If you agree to be contacted to participate in this research study please provide your email
address and/or phone number for correspondence with the researcher and to allow confirmation
of scheduled sessions.
______________________________________ ______________________________________
Email Address
Phone Number
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Appendix H
June 17, 2013
Dear Andrew Scott,
REB # 3670
Project, "Effects of a Heart Rate Variability Biofeedback Intervention on Athletes' Psychological
Response Following Injury"
Expiry Date: May 04, 2014
The Research Ethics Board of Wilfrid Laurier University has reviewed the above proposal and
determined that the proposal is ethically sound. If the research plan and methods should change
in a way that may bring into question the project's adherence to acceptable ethical norms, please
submit a "Request for Ethics Clearance of a Revision or Modification" form for approval before
the changes are put into place. This form can also be used to extend protocols past their expiry
date, except in cases where the project is more than four years old. Those projects require a new
REB application.
Please note that you are responsible for obtaining any further approvals that might be required to
complete your project.
If any participants in your research project have a negative experience (either physical,
psychological or emotional) you are required to submit an "Adverse Events Form" to the
Research Office within 24 hours of the event.
According to the Tri-Council Policy Statement, you must complete the "Annual/Final Progress
Report on Human Research Projects" form annually and upon completion of your project. All
forms, policies and procedures are available via the REB
website: http://www.wlu.ca/research/reb.
All the best for the successful completion of your project.
Yours sincerely,

Robert Basso, PhD
Chair, University Research Ethics Board
Wilfrid Laurier University
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Appendix I
Wilfrid Laurier
University

Founded 1911
Post-Study Letter of Information
Effects of a Heart Rate Variability Biofeedback Intervention on Athletes’ Psychological Response
Following Injury
Lead researcher: Scott Rollo
Supervisor: Jill Tracey, Ph.D.
We appreciate your participation in our study and want to thank you for spending the time to help us with
our research project. The purpose of this letter is to provide some extra details about the completed study.
Originally, you were informed that the study was designed to examine the psychological response of
athletes regarding the injury and rehabilitation process. You were told that various psychological
measures and physiological indices would be measured as you progressed through your injury recovery.
While this was a purpose of the investigation, complete study objectives have been only partially
disclosed, and there was more involved than originally explained.
The true purpose of this study was to evaluate the effectiveness of heart rate variability biofeedback
(HRV BFB), a form of psychological skills training intervention, to improve athletes’ psychological
response following an injury. Further, to examine the effects of HRV BFB training on self-efficacy,
perceived stress and anxiety, pain management, and the psychological responses of injured athletes. HRV
BFB effects on athletes’ physiological indices including HRV, HR, and respiration rate were also
assessed.
Upon study recruitment and being deemed eligible for study participation, you were randomly assigned to
one of three study groups. These groups involved a HRV BFB experimental group, HRV BFB placebo
group, and one group that received no training and acted as a control group. Participants assigned to either
the HRV BFB experimental group or HRV BFB placebo group received six BFB training sessions over a
3-week duration. Participants assigned to the control group received no training. Psychological outcome
questionnaires (measuring: self-efficacy, perceived stress, anxiety, pain management & psychological
responses of injured athletes) and the physiological assessment (measuring: HR, HRV, & respiratory rate)
were administered on four occasions over a 3-week duration for all participants. Data was collected to
examine the emotional experience and psychological responses of injured athletes as they progressed
through injury recovery. Different groups were required in order to evaluate if athletes' psychological
responses regarding injury and rehabilitation differed depending on the specific training they received. It
was important to conceal this information (i.e., true purpose, study objectives, procedures) as we wanted
behaviour to remain as natural as possible. Initial deception and/or concealment was neither arbitrary nor
capricious. In the interest of your right to withdraw at any time, you are now given the option to remove
your information from this research.
A potential contribution of this research is to assess whether using biofeedback in rehabilitation can serve
as a helpful intervention for those recovering from an injury. While other techniques have been used
within sport psychology, the use of biofeedback is a novel and new approach within the athletic
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rehabilitation setting. If successful, this research could speak to the effectiveness of biofeedback as an
available and useful rehabilitation tool within the athletic injury population.
We apologize for not providing you with complete and accurate information about the purpose,
objectives, and procedures of the study, but we hope that you understand why this was necessary to truly
understand the effects. This project has been reviewed and approved by the University Research Ethics
Board. If you feel that you have not been treated according to the descriptions in this form, or your rights
as a participant in research have been violated during the course of this project, you may contact Dr.
Robert Basso, Chair, University Research Ethics Board, Wilfrid Laurier University, (519) 884-1970,
extension 5225 or rbasso@wlu.ca.
We truly appreciate your participation in this study, and hope that you achieve a healthy and successful
recovery from your injury!
Scott Rollo MSc(c), BA
Department of Kinesiology & Physical Education
Wilfrid Laurier University
Waterloo, ON N2L 3C5
roll2100@mylaurier.ca
(519) 884-0710 ext. 4216
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Appendix J

Demographics Questionnaire
Please take a moment to complete the following questionnaire.
Name:
Age:
Sex: Male ☐

Female ☐

Prior to your current injury, have you had any previous history of athletic injury?
YES

NO

If YES, please specify:

What sport(s) were you participating in before sustaining your current injury?
During participation in which sport/athletic activity did your current injury occur?
For the sport in which you sustained your injury, what is the level of competition you are
involved in? Please circle the appropriate response and specify the club/team/organization
you are a part of.
Regional Team/Club ____________________
Varsity/University Level (i.e., OUA) _________________________
Provincial _________________________
National __________________________
Other _______________________________
What type of injury did you sustain (Location on body)? Please Circle.
Shoulder

Hip

Leg

Knee

Ankle

Other _________________________

When did you sustain your injury? Please check the one that applies.
Less than a week ago ☐
More than a week ago, Less than a month ago ☐
More than a month ago ☐
Are you currently out of practice and/or competition for the sport in which you sustained
your injury?
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NO

How long have you been told that you will be unable to participate in training and/or
competition for your sport?
Are you currently undergoing rehabilitation for your injury (i.e. physiotherapy, sports
medicine, acupuncture, massage therapy, etc.)?
YES

NO

If YES, please specify:
______________________________________________________________________________
Do you have a known heart condition (i.e., heart abnormalities, cardiac arrhythmias)?
YES

NO

Do you have a history and/or current diagnosis of any of the following?
Coronary artery disease
Heart disease
Heart failure
Hypertension
Chronic low blood pressure
Kidney disease

YES NO
YES NO
YES NO
YES NO
YES NO
YES NO

Are you currently receiving any formal training in any form of relaxation, biofeedback,
and/or breathing technique?
YES

NO

If YES, please specify:
______________________________________________________________________________
Are you receiving/participating in another psychological intervention (i.e., modeling,
imagery, stress management training) of any kind?
YES
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Appendix K
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Appendix L
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Appendix M
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Appendix N
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Appendix O
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Appendix P
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Appendix Q
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Appendix R
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Glossary
Frequency-domain HRV Measures: Spectrum of oscillatory components. Frequency-domain
methods involve a series of normalized IBI values to be processed through a mathematical
operation, such as a fast Fourier transform (FFT), to analyze the frequency information contained
in the recording. The result is displayed on a power spectrum, which shows a breakdown of all
the frequencies (oscillations) contained in each epoch.
HRV: Heart rate variability (HRV) refers to the beat-to-beat changes in the duration of RR
intervals (RRIs) in the electrocardiogram (ECG). Further, HRV can be expressed as variability
in the duration of interbeat intervals (IBIs) between consecutive heart beats.
Injury Severity: The number of days that have elapsed from the date of injury to the date of the
player’s return to full participation in team training and availability for match selection.
Moderate Athletic Injury: Classified as an injury with 8-28 days elapsing from the date of
injury to the date of the player’s return to full participation in team training and availability for
match selection.
Respiratory Sinus Arrhythmia (RSA): Variation in HR that accompanies respiration.
Resonant Frequency: The frequency of breathing, or respiratory rate, at which high-amplitude
HR oscillations are evoked, and power is maximized. The respiratory frequency at which RSA
is maximized.
Severe Athletic Injury: Classified as an injury extending up to 428 days from the date of injury
to the date of the player’s return to full participation in team training and availability for match
selection.
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